assay_id,doc_id,description,assay_type,assay_test_type,assay_category,assay_organism,assay_tax_id,assay_strain,assay_tissue,assay_cell_type,assay_subcellular_fraction,tid,relationship_type,confidence_score,curated_by,activity_count,assay_source,src_id,src_assay_id,chembl_id,updated_on,updated_by,orig_description,mc_tax_id,mc_organism,mc_target_type,mc_target_name,mc_target_accession,cell_id,bao_format,tissue_id,curation_comment,variant_id,aidx,job_id,log_id,ridx,tid_fixed
1,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,B,,,,,,,,,12052,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615117,2011-01-19 17:04:50,LJB Desc Spelling,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 microM.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
2,684,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,F,,,,,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615118,2006-04-20 15:42:24,admin_actype,Compound was evaluated for its ability to mobilise calcium in 1321NI cells,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
3,15453,,B,,,,,,,,,22229,U,0,Autocuration,0,ORIGINAL,1,,CHEMBL615119,2004-10-31 12:48:03,admin,,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
4,17841,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,B,,,Bos taurus,9913,,,,,104729,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615120,2006-12-04 17:22:55,BautoJPO,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]-CGS21680 as radioligand,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
5,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),F,,,Homo sapiens,9606,,,143B,,80001,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615121,2013-02-14 14:00:47,set cell-type from tid,In vitro cell cytotoxicity against 143-B cell lines(Human osteosarcoma cell line),,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
6,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),F,,,Homo sapiens,9606,,,143B,,80001,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615122,2013-02-14 14:00:47,set cell-type from tid,In vitro cell cytotoxicity against 143-B cell lines(Human osteosarcoma cell line),,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
7,13799,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,F,,,Mus musculus,10090,,,143B,,80001,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615123,2013-02-14 14:00:47,set cell-type from tid,Cytotoxic Activity of the compound was evaluated against 143B (TK-) tumor cells,,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
8,17774,In vitro cell cytotoxicity was determined against 143B cell line,F,,,Homo sapiens,9606,,,143B,,80001,N,1,Expert,14,ORIGINAL,1,,CHEMBL615124,2013-02-14 14:00:47,set cell-type from tid,In vitro cell cytotoxicity of the compound was determined against 143B cell line,,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
9,3801,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,F,,,Homo sapiens,9606,,,143B,,80001,N,1,Intermediate,8,ORIGINAL,1,,CHEMBL615125,2013-02-14 14:00:47,set cell-type from tid,Inhibitory activity against tumor osteosarcoma cell line 143B after 72h continuous exposure to compound,,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
10,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,F,,,Homo sapiens,9606,,,143B,,80001,N,1,Intermediate,7,ORIGINAL,1,,CHEMBL615126,2013-02-14 14:00:47,set cell-type from tid,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
11,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,F,,,Homo sapiens,9606,,,143B,,80001,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615127,2013-02-14 14:00:47,set cell-type from tid,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
12,17774,In vitro cell cytotoxicity was determined against 143B-LTK cell line,F,,,Homo sapiens,9606,,,143B,,80001,N,1,Expert,14,ORIGINAL,1,,CHEMBL615128,2013-02-14 14:00:47,set cell-type from tid,In vitro cell cytotoxicity of the compound was determined against 143B-LTK cell line,,,,,,163,BAO_0000219,,,,CLD0,0,0,CLD0,
13,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280,,,,,50185,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL857900,2006-04-20 15:44:13,admin_actype,"The compound was tested for minimum inhibitory concentration in S. aureus,147N penicillin sensitive S. aureus",,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
14,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280,,,,,50185,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615129,2006-04-20 15:44:13,admin_actype,"The compound was tested for minimum inhibitory concentration in S. aureus,147N penicillin sensitive S. aureus",,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
15,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280,,,,,50185,N,1,Intermediate,14,ORIGINAL,1,,CHEMBL615130,2006-04-20 15:44:13,admin_actype,"The compound was tested for minimum inhibitory concentration in S. aureus,147N penicillin sensitive S. aureus",,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
16,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280,,,,,50185,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615131,2006-04-20 15:44:13,admin_actype,"The compound was tested for minimum inhibitory concentration in S. aureus,147N penicillin sensitive S. aureus",,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
17,11347,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,A,,,Rattus norvegicus,10116,,,,,100122,D,9,Expert,4,ORIGINAL,1,,CHEMBL884521,2010-03-29 10:09:01,P450-type_corr,Inhibitory activity against cytochrome P450 enzyme(15 alpha hydroxylase hepatic progesterone) involved in hepatic drug metabolism,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
18,16474,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615132,2004-10-31 12:48:03,admin,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
19,10091,Inhibition of partially purified 15-lipoxygenase from human leukocytes,B,,,,,,,,,12054,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615133,2006-04-20 15:42:47,admin_actype,Inhibition of partially purified 15-lipoxygenase from human leukocytes,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
20,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,9,ORIGINAL,1,,CHEMBL615134,2006-04-20 15:42:47,admin_actype,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
21,16474,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615135,2006-04-20 15:43:24,admin_actype,Compound was evaluated for the percent incerase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
22,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615136,2006-04-20 15:43:24,admin_actype,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
23,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,B,,,,,,,,,12054,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615137,2006-04-20 15:43:24,admin_actype,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO) ;NI is no inhibition,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
24,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,B,,,,,,,,,12054,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615138,2006-04-20 15:43:24,admin_actype,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
25,14352,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",B,,,,,,,Endothelial cell,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL836324,2006-11-28 17:05:38,BautoJPO,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5M.",,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
26,5646,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,B,,,Oryctolagus cuniculus,9986,,,,,12054,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615139,2006-04-20 15:42:47,admin_actype,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
27,5646,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),B,,,Oryctolagus cuniculus,9986,,,,,12054,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615140,2011-01-19 17:05:05,LJB Desc Spelling,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 microM),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
28,10997,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,B,,,,,,,,,12426,H,8,Autocuration,10,ORIGINAL,1,,CHEMBL615141,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against 15-lipoxygenase in rat polymorphonuclear leukocytes,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
29,6309,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,B,,,soya bean,3847,,,,,12054,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615142,2006-04-20 15:42:47,admin_actype,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
30,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated,B,,,Glycine max,3847,,,,,12054,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615143,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against soyabean 15-lipoxygenase was evaluated,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
31,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,B,,,Glycine max,3847,,,,,12054,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615144,2011-01-19 17:04:21,LJB Desc Spelling,Inhibitory activity of the compound against soyabean 15-lipoxygenase was evaluated at 100 uM,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
32,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,B,,,Glycine max,3847,,,,,12054,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL872867,2011-01-19 17:05:11,LJB Desc Spelling,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soyabean at a concentration of 10 microM.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
33,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,B,,,Glycine max,3847,,,,,12054,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615145,2011-01-19 17:04:36,LJB Desc Spelling,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soyabean at a concentration of 100 microM.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
34,13622,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,B,,,Glycine max,3847,,,,,12054,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615146,2006-04-20 15:42:47,admin_actype,Compound was tested in vitro for inhibition of 15-lipoxygenase soyabean,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
35,13622,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,B,,,Glycine max,3847,,,,,12054,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615147,2011-01-19 17:05:04,LJB Desc Spelling,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soyabean,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
36,11347,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,A,,,Rattus norvegicus,10116,,,,,22224,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL615148,2010-03-29 10:09:01,P450-type_corr,Inhibitory activity against cytochrome P450 enzyme(16 alpha hydroxylase hepatic progesterone) involved in hepatic drug metabolism,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
37,5926,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,B,,,Escherichia coli,562,,,,,22226,U,0,Autocuration,26,ORIGINAL,1,,CHEMBL615149,2006-04-20 15:43:43,admin_actype,Binding affinity of the compound against bacterial 16S rRNA using mass spectrometry based assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
38,4567,Dissociation constant with dimeric 16S rRNA RNA construct B,B,,,,,,,,,22226,U,0,Autocuration,9,ORIGINAL,1,,CHEMBL615150,2010-10-26 17:10:29,SQL-abbr-desc,Dissociation constant of the compound with dimeric 16S rRNA RNA construct B,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
39,3782,Dissociation constant towards 16S rRNA construct A,B,,,,,,,,,22222,M,3,Intermediate,6,ORIGINAL,1,,CHEMBL615151,2010-10-26 17:10:29,SQL-abbr-desc,Dissociation constant of the compound towards 16S rRNA construct A,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
40,3782,Dissociation constant towards 16S rRNA construct B,B,,,,,,,,,22222,M,3,Intermediate,6,ORIGINAL,1,,CHEMBL615152,2010-10-26 17:10:29,SQL-abbr-desc,Dissociation constant of the compound towards 16S rRNA construct B,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
41,4466,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,B,,,Escherichia coli,562,,,,,100263,M,3,Expert,14,ORIGINAL,1,,CHEMBL615153,2013-04-15 16:29:30,reset_complex,Compound was evaluated for the binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
42,6592,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,B,,,Escherichia coli,562,,,,,100263,M,3,Expert,48,ORIGINAL,1,,CHEMBL615154,2006-04-20 15:43:44,admin_actype,Tested for binding affinity of the compound towards 16S ribosomal RNA A-site of Escherichia coli,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
43,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615155,2006-11-28 16:58:32,BautoJPO,Inhibitory activity against human placenta 17beta-hydroxysteroid dehydrogenase type 2 (17beta-HSD type 2),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
44,898,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615156,2006-11-23 12:25:28,BautoJPO,Inhibitory constant against human placenta 17beta-hydroxysteroid dehydrogenase type 2 (17beta-HSD type 2),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
45,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,B,,,Homo sapiens,9606,,,,,20001,H,8,Autocuration,10,ORIGINAL,1,,CHEMBL615157,2006-11-28 16:58:32,BautoJPO,The compound was tested at a concentration of 1microM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
46,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,B,,,Homo sapiens,9606,,,,,20001,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615158,2006-11-23 12:25:28,BautoJPO,The compound was tested at a concentration of 1uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
47,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",B,,,Rattus norvegicus,10116,,Testis,,,12971,D,9,Expert,1,ORIGINAL,1,,CHEMBL615159,2006-04-20 15:42:47,admin_actype,"Inhibition of 117-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,,,,,,BAO_0000221,473,,,CLD0,0,0,CLD0,
48,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",B,,,Rattus norvegicus,10116,,Testis,,,12971,D,9,Expert,3,ORIGINAL,1,,CHEMBL615172,2006-04-20 15:42:47,admin_actype,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,,,,,,BAO_0000221,473,,,CLD0,0,0,CLD0,
49,10691,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",B,,,Rattus norvegicus,10116,,,,,12971,D,9,Expert,8,ORIGINAL,1,,CHEMBL615173,2006-11-28 16:58:32,BautoJPO,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase at 100 microM from rat testes microsomal preparation",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
50,10691,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",B,,,Rattus norvegicus,10116,,,,,12971,D,9,Expert,1,ORIGINAL,1,,CHEMBL615174,2006-11-28 16:58:32,BautoJPO,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase at 100 microM from rat testes microsomal preparation",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
51,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL884518,2006-11-23 12:26:19,BautoJPO,Inhibitory activity against human placenta 17beta-hydroxysteroid dehydrogenase type 2 (17beta-HSD type 2),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
52,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),B,,,,,,,,,11512,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615175,2006-11-28 16:58:32,BautoJPO,Compound was tested for the inhibition of 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD type 1),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
53,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,B,,,,,,,,,11512,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615176,2011-01-19 17:04:32,LJB Desc Spelling,Compound was tested for the inhibition of 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD type 1) at 1 microM concentration,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
54,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,B,,,,,,,,,11512,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615177,2011-01-19 17:05:00,LJB Desc Spelling,Compound was tested for the inhibition of 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD type 1) at 10 microM concentration,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
55,15103,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,B,,,Rattus norvegicus,10116,,,,Membrane,104740,D,5,Autocuration,8,ORIGINAL,1,,CHEMBL615178,2005-02-28 00:00:00,paustin,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
56,5116,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615179,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity of the compound against ovarian cancer cell line (1A-9) of humans was determined,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
57,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,F,,,Rattus norvegicus,10116,,,Oocyte,,104835,D,7,Autocuration,13,ORIGINAL,1,,CHEMBL615180,2006-04-24 00:00:00,ylight,Functional antagonism of the compound evaluated by electrical assays in Xenopus oocytes expressing the 1A/2A NMDA receptor subtype.,,,,,,1758,BAO_0000219,,,,CLD0,0,0,CLD0,
58,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,F,,,Rattus norvegicus,10116,,,Oocyte,,104821,D,7,Autocuration,13,ORIGINAL,1,,CHEMBL615181,2006-04-24 00:00:00,ylight,Functional antagonism of the compound evaluated by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor subtype.,,,,,,1758,BAO_0000219,,,,CLD0,0,0,CLD0,
59,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,F,,,Rattus norvegicus,10116,,,Oocyte,,104848,D,7,Autocuration,13,ORIGINAL,1,,CHEMBL615182,2006-04-24 00:00:00,ylight,Functional antagonism of the compound evaluated by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor subtype.,,,,,,1758,BAO_0000219,,,,CLD0,0,0,CLD0,
60,4787,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Expert,10,ORIGINAL,1,,CHEMBL615183,2013-02-14 14:00:47,set cell-type from tid,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
61,4787,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615184,2013-02-14 14:00:47,set cell-type from tid,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
62,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615185,2013-02-14 14:00:47,set cell-type from tid,Cytotoxic activity of the compound against human ovarian cancer (1A9) cell line,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
63,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615186,2013-02-14 14:00:47,set cell-type from tid,Cytotoxic activity of the compound against human ovarian cancer (1A9) cell line; ND=Not determined,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
64,6726,Effective dose of compound against replication of 1A9 cell line was evaluated,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615187,2013-02-14 14:00:47,set cell-type from tid,Effective dose of compound against replication of 1A9 cell line was evaluated,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
65,3455,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Expert,26,ORIGINAL,1,,CHEMBL885343,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
66,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615188,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxicity of the compound evaluated against human ovarian cancer (1A9 cell line),,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
67,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615189,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxicity of the compound evaluated against human ovarian cancer (1A9 cell line); NA is not active,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
68,5726,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615190,2013-02-14 14:00:47,set cell-type from tid,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20microg/mL,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
69,3395,Inhibitory activity against Taxol resistant 1A9 cell lines,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615191,2013-02-14 14:00:47,set cell-type from tid,Inhibitory activity against Taxol resistant 1A9 cell lines,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
70,3415,Cytotoxicity against human ovarian cancer (1A9) cell lines.,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Expert,6,ORIGINAL,1,,CHEMBL615192,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity against human ovarian cancer(1A9) cell lines.,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
71,3415,Percentage inhibition of human ovarian cancer (1A9) cell lines.,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Expert,1,ORIGINAL,1,,CHEMBL827083,2013-02-14 14:00:47,set cell-type from tid,Percentage inhibition of human ovarian cancer(1A9) cell lines.,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
72,17099,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Expert,26,ORIGINAL,1,,CHEMBL615193,2013-02-14 14:00:47,set cell-type from tid,Effective dose of the compound required for inhibitory activity against 1A9 human tumor cell line,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
73,17099,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615194,2013-02-14 14:00:47,set cell-type from tid,Percent inhibition of the compound against 1A9 human tumor cell line at 0.10 microg/mL,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
74,17099,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615195,2013-02-14 14:00:47,set cell-type from tid,Percent inhibition of the compound against 1A9 human tumor cell line at <0.00008 microg/mL,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
75,17099,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,F,,,Homo sapiens,9606,,,1A9,,80002,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615196,2013-02-14 14:00:47,set cell-type from tid,Percent inhibition of the compound against 1A9 human tumor cell line at >10microg/mL,,,,,,506,BAO_0000219,,,,CLD0,0,0,CLD0,
76,17721,Inhibitory concentration against Jurkat cells,F,,,Homo sapiens,9606,,,Jurkat,,81072,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615197,2013-02-14 14:00:47,set cell-type from tid,Inhibitory concentration of the compound against Jurkat cells,,,,,,503,BAO_0000219,,,,CLD0,0,0,CLD0,
77,1229,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,F,,,,,,,SCLC,,22226,U,0,Intermediate,3,ORIGINAL,1,,CHEMBL615198,2013-02-14 14:00:47,set cell-type from tid,In vitro anticancer activity against 2 SCLC cell line; inactive,,,,,,333,BAO_0000219,,,,CLD0,0,0,CLD0,
78,11347,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,A,,,Rattus norvegicus,10116,,,,,100121,D,9,Expert,4,ORIGINAL,1,,CHEMBL615199,2010-03-29 10:09:01,P450-type_corr,Inhibitory activity against cytochrome P450 enzyme(2 alpha hydroxylase hepatic progesterone) involved in hepatic drug metabolism,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
79,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",B,,,,,,,,,11231,H,8,Expert,1,ORIGINAL,1,,CHEMBL615200,2006-04-20 15:42:47,admin_actype,"In vitro inhibitory concentration required against human 2,3-oxidosqualene cyclase",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
80,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",B,,,,,,,,,11231,H,8,Expert,21,ORIGINAL,1,,CHEMBL615201,2006-04-20 15:42:47,admin_actype,"In vitro inhibitory concentration required against human 2,3-oxidosqualenecyclase",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
81,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",B,,,,,,,,,11231,H,8,Expert,4,ORIGINAL,1,,CHEMBL615202,2006-11-23 12:25:28,BautoJPO,"In vitro percent inhibition against human 2,3-oxidosqualenecyclase at 100nM",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
82,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",B,,,Candida albicans,5476,,,,Microsome,11231,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615203,2004-10-31 12:48:03,admin,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",,,,,,,BAO_0000251,,,,CLD0,0,0,CLD0,
83,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",B,,,Candida albicans,5476,,,,Microsome,11231,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615204,2004-10-31 12:48:03,admin,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",,,,,,,BAO_0000251,,,,CLD0,0,0,CLD0,
84,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",B,,,Saccharomyces cerevisiae,4932,,,,Microsome,11231,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615205,2004-10-31 12:48:03,admin,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",,,,,,,BAO_0000251,,,,CLD0,0,0,CLD0,
85,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",B,,,Saccharomyces cerevisiae,4932,,,,Microsome,11231,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615206,2004-10-31 12:48:03,admin,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",,,,,,,BAO_0000251,,,,CLD0,0,0,CLD0,
86,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",B,,,Sus scrofa,9823,,Liver,,Microsome,12083,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615207,2004-10-31 12:48:03,admin,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
87,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",B,,,Rattus norvegicus,10116,,,,,11231,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL827084,2006-04-20 15:42:47,admin_actype,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
88,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",B,,,Rattus norvegicus,10116,,,,,11231,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615208,2006-04-20 15:42:47,admin_actype,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
89,791,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",B,,,Rattus norvegicus,10116,,,,,11231,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615209,2006-04-20 15:43:45,admin_actype,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
90,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116,,Liver,,Microsome,12083,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615210,2004-10-31 12:48:03,admin,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
91,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116,,Liver,,Microsome,12083,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615211,2004-10-31 12:48:03,admin,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
92,153,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116,,Liver,,Microsome,12083,D,9,Autocuration,3,ORIGINAL,1,,CHEMBL615212,2006-04-20 15:42:47,admin_actype,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
93,8269,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),B,,,,,,,,,11377,H,8,Expert,13,ORIGINAL,1,,CHEMBL615213,2005-02-16 00:00:00,rmyers,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
94,8269,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,B,,,,,,,,,11377,H,8,Expert,18,ORIGINAL,1,,CHEMBL615273,2005-02-16 00:00:00,rmyers,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
95,17653,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Expert,18,ORIGINAL,1,,CHEMBL615274,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
96,14277,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615275,2013-02-14 14:00:47,set cell-type from tid,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
97,1717,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615276,2013-02-14 14:00:47,set cell-type from tid,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
98,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615277,2013-02-14 14:00:47,set cell-type from tid,In vitro effective concentration of the compound against hepatitis B virus was determined in 2.2.15 cells,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
99,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615326,2013-02-14 14:00:47,set cell-type from tid,In vitro effective concentration of the compound against hepatitis B virus was determined in 2.2.15 cells; Not determined,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
100,17653,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,F,,,Hepatitis B virus,10407,,,,,50606,N,1,Expert,18,ORIGINAL,1,,CHEMBL883130,2006-04-20 15:42:24,admin_actype,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
101,13105,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL884519,2013-02-14 14:00:47,set cell-type from tid,Ability of the compound to inhibit the episomal HBV-DNA in 2.2.15 cells.,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
102,1717,Concentration required to inhibit 50% of 2.2.15 cell line,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615327,2013-02-14 14:00:47,set cell-type from tid,Concentration of the compound required to inhibit 50% of 2.2.15 cell line,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
103,13105,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,A,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615328,2013-02-14 14:00:47,set cell-type from tid,Anti viral activity of the compound against 2.2.15 cells(concentration required to reduce the log phase cell growth by 50%).,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
104,13600,Cytotoxic activity of compound against uninfected 2.2.15 cells.,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,13,ORIGINAL,1,,CHEMBL615329,2006-04-20 15:42:21,admin_actype,Cytotoxic activity of compound against uninfected 2.2.15 cells,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
105,13467,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,14,ORIGINAL,1,,CHEMBL615330,2010-10-26 17:10:29,SQL-abbr-desc,Anti hepatitis-B virus activity of the compound was evaluated in 2.2.15 cells.,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
106,17477,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",F,,,Hepatitis B virus,10407,,,HepG2 2.2.15,,50606,N,1,Expert,17,ORIGINAL,1,,CHEMBL615331,2006-04-20 15:42:24,admin_actype,Concentration of the compound inhibiting the replication of HBV in 2.2.15 cells by DNA hybridization assay,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
107,1593,In vitro anti-HBV activity in 2.2.15 cells,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615332,2010-10-26 16:15:59,SQL-abbr-desc,In vitro anti-HBV activity of the compound was tested in 2.2.15 cells,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
108,1593,In vitro anti-HBV activity in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615333,2010-10-26 16:15:59,SQL-abbr-desc,In vitro anti-HBV activity of the compound was tested in 2.2.15 cells; Not determined,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
109,15089,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,10,ORIGINAL,1,,CHEMBL615334,2006-04-20 15:42:24,admin_actype,The compound was tested in vitro for the antiHBV activity against 2.2.15 cells,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
110,15089,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615335,2006-04-20 15:42:24,admin_actype,The compound was tested in vitro for the antiHBV activity in 2.2.15 cells,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
111,1593,Cytotoxicity in 2.2.15 cells,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615336,2010-10-26 16:15:59,SQL-abbr-desc,Cytotoxicity of the compound was tested in 2.2.15 cells,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
112,1593,Cytotoxicity in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615337,2010-10-26 16:15:59,SQL-abbr-desc,Cytotoxicity of the compound was tested in 2.2.15 cells; Not determined,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
113,13600,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,13,ORIGINAL,1,,CHEMBL615338,2006-04-20 15:42:47,admin_actype,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
114,13467,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,14,ORIGINAL,1,,CHEMBL615339,2006-04-20 15:42:47,admin_actype,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
115,13467,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606,,,HepG2 2.2.15,,50587,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615340,2004-10-31 12:48:03,spell,Selectivty index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,,,,,,5553,BAO_0000218,,,,CLD0,0,0,CLD0,
116,14764,Antiviral activity against HBV was determined in 2.215 cell line,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615341,2013-02-14 14:00:47,set cell-type from tid,Antiviral activity against HBV was determined in 2.215 cell line,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
117,6531,Inhibition of 20-HETE synthesis in human renal microsomes,B,,,Homo sapiens,9606,,,,Microsome,22226,U,0,Autocuration,12,ORIGINAL,1,,CHEMBL615342,2006-04-20 15:42:47,admin_actype,Inhibitory activity of compound against 20-HETE synthase was evaluated by measuring the inhibition of 20-HETE synthesis in human renal microsomes,,,,,,,BAO_0000251,,,,CLD0,0,0,CLD0,
118,17322,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,B,,,,,,,,,22226,U,0,Autocuration,32,ORIGINAL,1,,CHEMBL615343,2006-11-28 16:58:32,BautoJPO,Inhibitory activity of the compound against 20HETE production from arachidonic acid using human renal microsome 20-HETE synthase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
119,17072,Inhibitory concentration against 2008 (ovarian) cells,F,,,Homo sapiens,9606,,,2008,,80612,N,1,Intermediate,12,ORIGINAL,1,,CHEMBL615344,2013-02-14 14:00:47,set cell-type from tid,Inhibitory concentration of the compound against 2008 (ovarian) cells,,,,,,388,BAO_0000219,,,,CLD0,0,0,CLD0,
120,16936,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,F,,,Homo sapiens,9606,,,2008,,80612,N,1,Intermediate,8,ORIGINAL,1,,CHEMBL615345,2013-02-14 14:00:47,set cell-type from tid,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,,,,,,388,BAO_0000219,,,,CLD0,0,0,CLD0,
121,16936,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),F,,,Homo sapiens,9606,,,2008,,80612,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615346,2013-02-14 14:00:47,set cell-type from tid,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),,,,,,388,BAO_0000219,,,,CLD0,0,0,CLD0,
122,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,F,,,Homo sapiens,9606,,,2008,,80612,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615347,2013-02-14 14:00:47,set cell-type from tid,Direct cytotoxicity against the selected tumour cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,,,,,,388,BAO_0000219,,,,CLD0,0,0,CLD0,
123,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,F,,,Homo sapiens,9606,,,2008,,80612,N,1,Intermediate,14,ORIGINAL,1,,CHEMBL615348,2013-02-14 14:00:47,set cell-type from tid,Direct cytotoxicity against the selected tumour cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,,,,,,388,BAO_0000219,,,,CLD0,0,0,CLD0,
124,10797,In vitro inhibition of 2008/R ovarian cancer cell line,F,,,Homo sapiens,9606,,,2008/R,,80613,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL827085,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibition of 2008/R ovarian cancer cell line,,,,,,561,BAO_0000219,,,,CLD0,0,0,CLD0,
125,10797,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,F,,,Homo sapiens,9606,,,2008/R,,80613,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615349,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,,,,,,561,BAO_0000219,,,,CLD0,0,0,CLD0,
126,10797,In vitro inhibition of 2008/S ovarian cancer cell line,F,,,Homo sapiens,9606,,,2008/S,,80614,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615350,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibition of 2008/S ovarian cancer cell line,,,,,,389,BAO_0000219,,,,CLD0,0,0,CLD0,
127,10797,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,F,,,Homo sapiens,9606,,,2008/S,,80614,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615351,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,,,,,,389,BAO_0000219,,,,CLD0,0,0,CLD0,
128,4823,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,B,,,Homo sapiens,9606,,,,,116833,D,7,Expert,19,ORIGINAL,1,,CHEMBL615352,2006-04-20 15:42:47,admin_actype,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,,,,,,,BAO_0000220,,,,CLD0,0,0,CLD0,
129,12912,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,B,,,Homo sapiens,9606,,Brain,,,116833,D,7,Intermediate,7,ORIGINAL,1,,CHEMBL615353,2006-04-20 15:42:47,admin_actype,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,,,,,,,BAO_0000220,955,,,CLD0,0,0,CLD0,
130,2957,Inhibition of chymotrypsin-like activity of 20S proteasome,B,,,,,,,,,100256,S,2,Expert,35,ORIGINAL,1,,CHEMBL615354,2006-04-20 15:42:47,admin_actype,Compound was tested for the inhibition of chymotrypsin-like activity of 20S proteasome,,,,,,,BAO_0000220,,,,CLD0,0,0,CLD0,
131,2957,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,B,,,,,,,,,100256,S,2,Expert,1,ORIGINAL,1,,CHEMBL615355,2011-01-19 17:04:43,LJB Desc Spelling,Compound was tested for the inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,,,,,,,BAO_0000220,,,,CLD0,0,0,CLD0,
132,3260,Inhibitory activity against 20S proteosome,B,,,,,,,,,100256,S,2,Intermediate,2,ORIGINAL,1,,CHEMBL615356,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against 20S proteosome,,,,,,,BAO_0000220,,,,CLD0,0,0,CLD0,
133,3451,Compound was tested for inhibitory activity against tryptase,B,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,7,ORIGINAL,1,,CHEMBL615357,2006-04-20 15:43:45,admin_actype,Compound was tested for inhibitory activity against tryptase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
134,13885,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615358,2013-12-04 14:26:25,george_spelling,Concentration required to inhibit 50% of extracellular circular repication of HBV DNA using 2215 cell line,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
135,13885,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,F,,,Homo sapiens,9606,,,HepG2,,81020,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL827086,2013-12-04 14:26:25,george_spelling,Concentration required to inhibit 50% of intracellular circular repication of HBV DNA using 2215 cell line,,,,,,726,BAO_0000219,,,,CLD0,0,0,CLD0,
136,3676,Compound was tested for the inhibition of Alpha-glucosidase,B,,,,,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615359,2006-04-20 15:42:47,admin_actype,Compound was tested for the inhibition of Alpha-glucosidase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
137,6043,Inhibitory concentration against human neutrophil elastase (HNE),B,,,,,,,,,235,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615360,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory concentration of the compound against human neutrophil elastase (HNE),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
138,11140,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,F,,,Rattus norvegicus,10116,,Heart,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615361,2006-11-28 17:05:08,BautoJPO,Change in heart rate was expressed in percent at at a dose 0.002mg/kg iv in anaesthasized rat,,,,,,,BAO_0000218,948,,,CLD0,0,0,CLD0,
139,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615362,2006-04-20 15:44:13,admin_actype,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
140,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Expert,6,ORIGINAL,1,,CHEMBL615363,2006-04-20 15:44:13,admin_actype,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
141,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,B,,,,,,,,,19640,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615364,2006-04-20 15:44:13,admin_actype,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
142,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Expert,7,ORIGINAL,1,,CHEMBL615365,2004-10-31 12:48:03,admin,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
143,11365,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,F,,,Mus musculus,10090,,,P338,,80360,N,1,Intermediate,7,ORIGINAL,1,,CHEMBL615366,2013-02-14 14:00:47,set cell-type from tid,In Vitro evaluation of the compound for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,,,,,,524,BAO_0000219,,,,CLD0,0,0,CLD0,
144,11365,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,F,,,Mus musculus,10090,,,P338,,80360,N,1,Intermediate,14,ORIGINAL,1,,CHEMBL615367,2013-02-14 14:00:47,set cell-type from tid,In Vitro evaluation of the compound for the growth inhibition of Subline (P388/CP) Leukemia cell lines,,,,,,524,BAO_0000219,,,,CLD0,0,0,CLD0,
145,11803,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,F,,,Homo sapiens,9606,,,PBL,,80384,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615368,2013-02-14 14:00:47,set cell-type from tid,Compound was evaluated for the inhibition of cell replication human pheripheral blood lymphocytes (PBL's).,,,,,,554,BAO_0000219,,,,CLD0,0,0,CLD0,
146,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,F,,,Ovis aries,9940,,,,,22226,U,0,Autocuration,6,ORIGINAL,1,,CHEMBL615369,2006-04-20 15:42:23,admin_actype,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
147,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,F,,,Ovis aries,9940,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615370,2006-04-20 15:42:23,admin_actype,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
148,12278,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),B,,,,,,,,,191,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615673,2006-04-20 15:42:47,admin_actype,Compound is evaluted in vitro for the inhibition single mutant of HIV-1 RT (Y181C),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
149,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,F,,,Homo sapiens,9606,,,CEM/MTX,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615674,2013-12-04 13:50:16,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine (3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc.10e-5,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
150,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,F,,,Homo sapiens,9606,,,CEM/MTX,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615675,2013-12-04 13:50:17,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine (3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc.10e-6,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
151,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,F,,,Homo sapiens,9606,,,CCRF-CEM,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615676,2013-12-04 13:50:18,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc.10e-7,,,,,,635,BAO_0000219,,,,CLD0,0,0,CLD0,
152,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,F,,,Homo sapiens,9606,,,CCRF-CEM,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615677,2013-12-04 13:50:18,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc.10e-4,,,,,,635,BAO_0000219,,,,CLD0,0,0,CLD0,
153,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,F,,,Homo sapiens,9606,,,CCRF-CEM,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615678,2013-12-04 13:50:19,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc.10e-5,,,,,,635,BAO_0000219,,,,CLD0,0,0,CLD0,
154,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,F,,,Homo sapiens,9606,,,CCRF-CEM,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615679,2013-12-04 13:50:19,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc.10e-6,,,,,,635,BAO_0000219,,,,CLD0,0,0,CLD0,
155,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,F,,,Homo sapiens,9606,,,CEM/MTX,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615680,2013-12-04 13:50:20,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in at conc.10e-7.,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
156,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,F,,,Homo sapiens,9606,,,CEM/MTX,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615681,2013-12-04 13:50:21,george_spelling,Compound was evaluated for its inhibitiry effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc.10e-4,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
157,16992,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,B,,,,,,,,,104290,H,6,Autocuration,67,ORIGINAL,1,,CHEMBL857972,2006-04-20 15:44:08,admin_actype,In vitro binding affinity of the compound towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
158,10543,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,F,,,Streptococcus pyogenes,1314,,,,,50264,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL857899,2013-02-14 13:59:31,set organism from tid,Minimum inhibitory concentration of compound against S.pyogenus septicemia in the mouse,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
159,17833,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),F,,,Human herpesvirus 3,10335,,,,,50527,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615371,2013-12-04 14:07:07,george_spelling,Antiviral activity of the compound against 07/1 strain of thymidine kinase negetive(TK-) Varicella-Zoster Virus (VZV),,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
160,17290,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,F,,,Human herpesvirus 3,10335,,,HEL,,50527,N,1,Expert,20,ORIGINAL,1,,CHEMBL615372,2006-04-20 15:42:24,admin_actype,Antiviral activity of the compound against 07/1 strain of VZV,,,,,,468,BAO_0000218,,,,CLD0,0,0,CLD0,
161,17290,Antiviral activity against 07/1 strain of VZV; ND: No data,F,,,Human herpesvirus 3,10335,,,,,50527,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615373,2010-10-26 17:10:29,SQL-abbr-desc,Antiviral activity of the compound against 07/1 strain of VZV; ND: No data,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
162,17290,Antiviral activity against 07/1 strain of VZV; ND=No data,F,,,Human herpesvirus 3,10335,,,,,50527,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615374,2010-10-26 17:10:29,SQL-abbr-desc,Antiviral activity of the compound against 07/1 strain of VZV; ND=No data,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
163,10932,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",F,,,escherichia cloac,561,,,,,50145,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615375,2006-11-28 17:05:08,BautoJPO,"Antibacterial activity was determined against gram negative organism, E. cloac(MA2646)",,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
164,9707,Ratio of Ki at A2 to Ki at A1 receptors,B,,,,,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615376,2004-10-31 12:48:03,admin,Ratio of Ki at A2 to Ki at A1 receptors,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
165,2346,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",B,,,Candida albicans,5476,,,,,11143,H,8,Expert,29,ORIGINAL,1,,CHEMBL615377,2006-04-20 15:42:47,admin_actype,"Compound was evaluated in vitro for inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay",,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
166,2205,"Inhibition of 1,3-beta-glucan synthase",B,,,Candida glabrata CBS 138,284593,,,,,18077,H,8,Expert,17,ORIGINAL,1,,CHEMBL615378,2006-04-20 15:42:47,admin_actype,"Concentration required for 50% inhibition of 1,3-beta-glucan synthase compared to control",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
167,11900,Inhibition of growth of 1-87 human tumor cell line,F,,,Homo sapiens,9606,,,1-87 tumor cell line,,80609,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615379,2013-02-14 14:00:47,set cell-type from tid,Inhibition of growth of 1-87 human tumor cell line,,,,,,832,BAO_0000219,,,,CLD0,0,0,CLD0,
168,14864,Inhibition of 1-lipoxygenase (LOX)in RBL cells,B,,,Rattus norvegicus,10116,,,RBL,,12166,D,9,Expert,8,ORIGINAL,1,,CHEMBL615380,2006-04-20 15:42:47,admin_actype,The compound was tested for the concentration to inhibit 50% 1-lipoxygenase (LOX),,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
169,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO),B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,7,ORIGINAL,1,,CHEMBL615381,2006-04-20 15:42:47,admin_actype,Inhibitory activity against soybean 1-lipoxygenase (SLO),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
170,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,2,ORIGINAL,1,,CHEMBL615382,2006-04-20 15:42:47,admin_actype,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
171,16474,% inhibition against soybean 1-lipoxygenase (SLO),B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,10,ORIGINAL,1,,CHEMBL615383,2006-04-20 15:43:24,admin_actype,% inhibition against soybean 1-lipoxygenase (SLO),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
172,16474,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,5,ORIGINAL,1,,CHEMBL615384,2006-04-20 15:43:24,admin_actype,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
173,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615385,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
174,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,2,ORIGINAL,1,,CHEMBL615386,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
175,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615387,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
176,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615388,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
177,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615214,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
178,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL827087,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
179,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615215,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
180,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615216,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
181,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615217,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
182,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615218,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
183,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,B,,,Glycine max,3847,,,,,100171,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615219,2004-10-31 12:48:03,admin,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
184,10413,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,B,,,Mus musculus,10090,,,,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL615220,2013-12-04 14:40:30,george_spelling,Evaluated for inhibitory activity on 10-formyltetrahydrofolate syhthetase(L cell) at folate substrate concentration of 100microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
185,16929,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),F,,,Mus musculus,10090,,,C3H 10T1/2,,80049,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615221,2013-02-14 14:00:47,set cell-type from tid,Cells were harvested and were assayed for luciferase and -galactosidase activities.(Transcriptional activity),,,,,,294,BAO_0000219,,,,CLD0,0,0,CLD0,
186,1229,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,F,,,,,,,NSCLC,,22226,U,0,Intermediate,3,ORIGINAL,1,,CHEMBL615222,2013-02-14 14:00:47,set cell-type from tid,In vitro anticancer activity against 11 NSCLC cell line; inactive,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
187,16587,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),B,,,,,,,,,11489,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615223,2006-04-20 15:42:47,admin_actype,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
188,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),B,,,,,,,,,11862,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615224,2006-04-20 15:42:47,admin_actype,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
189,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,B,,,,,,,,,11862,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615225,2006-04-20 15:42:47,admin_actype,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
190,16587,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,B,,,,,,,,,11489,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615226,2006-11-23 12:25:28,BautoJPO,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
191,16587,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,B,,,,,,,,,11862,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615227,2004-10-31 12:48:03,admin,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
192,8058,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,F,,,Bos taurus,9913,,,,,12347,D,9,Expert,15,ORIGINAL,1,,CHEMBL615228,2006-04-20 15:42:47,admin_actype,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
193,9065,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,B,,,Rattus norvegicus,10116,,,,,100120,D,9,Expert,1,ORIGINAL,1,,CHEMBL615229,2006-11-28 17:05:08,BautoJPO,Compound was evaluated for its effect on adrenal 11 beta hydroxylase activity at 10E-4M; No significant effect,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
194,8865,Inhibition of 11 beta-hydroxylase from rat adrenal gland,B,,,Rattus norvegicus,10116,,Adrenal gland,,,100120,D,9,Expert,7,ORIGINAL,1,,CHEMBL615230,2006-04-20 15:42:47,admin_actype,Compound was tested for inhibition of 11 beta-hydroxylase from rat adrenals,,,,,,,BAO_0000221,2369,,,CLD0,0,0,CLD0,
195,9066,Inhibition of rat adrenal 11-beta-hydroxylase,B,,,Rattus norvegicus,10116,,,,,100120,D,9,Expert,7,ORIGINAL,1,,CHEMBL615231,2006-11-28 16:58:32,BautoJPO,Inhibition of 11beta-hydroxylase from adrenals of rat,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
196,8394,Inhibition of rat adrenal 11-beta-hydroxylase,B,,,Rattus norvegicus,10116,,,,,100120,D,9,Expert,6,ORIGINAL,1,,CHEMBL884520,2006-04-20 15:42:47,admin_actype,Inhibitory activity of the compound was tested against 11 beta- hydroxylase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
197,8394,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,B,,,Rattus norvegicus,10116,,,,,100120,D,9,Expert,1,ORIGINAL,1,,CHEMBL615232,2006-11-28 17:05:08,BautoJPO,Inhibitory activity of the compound was tested against 11 beta- hydroxylase at 10E-5 M,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
198,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,B,,,,,,,,,10328,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615233,2011-01-19 17:04:28,LJB Desc Spelling,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
199,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,B,,,,,,,,,11490,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL827088,2011-01-19 17:04:49,LJB Desc Spelling,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
200,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,B,,,,,,,,,11490,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615234,2011-01-19 17:04:49,LJB Desc Spelling,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
201,9295,Compound was tested for the percent of inhibition against 12-LO at 10 uM,F,,,,,,,,,11134,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615235,2006-11-28 16:58:32,BautoJPO,Compound was tested for the percent of inhibition against 12-LO at 10microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
202,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615236,2011-01-19 17:05:01,LJB Desc Spelling,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
203,13622,Compound was tested in vitro for inhibition of 12-LO human platelet,B,,,,,,,,,11134,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615237,2006-04-20 15:42:47,admin_actype,Compound was tested in vitro for inhibition of 12-LO human platelet,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
204,12079,Inhibitory concentration against human platelet 12-lipoxygenase,F,,,,,,,,,11134,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615238,2006-04-20 15:42:47,admin_actype,Inhibitory concentration against human platelet 12-lipooxygenase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
205,13622,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,B,,,,,,,,,11134,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615239,2011-01-19 17:04:46,LJB Desc Spelling,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
206,12079,Inhibitory concentration against human platelet 12-lipoxygenase,F,,,Homo sapiens,9606,,,,,11134,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615240,2006-04-20 15:42:47,admin_actype,Inhibitory concentration against human platelet 12-lipooxygenase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
207,13500,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,B,,,,,,,,,11835,H,8,Expert,27,ORIGINAL,1,,CHEMBL615241,2006-04-20 15:42:47,admin_actype,Compound was tested for inhibition of 12-LO (12-lipoxygenase) as inhibition of 12(S)-HETE biosynthesis in mouse epidermal homogenates,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
208,13723,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,B,,,,,,,,,11601,H,8,Expert,22,ORIGINAL,1,,CHEMBL615242,2006-11-28 17:05:08,BautoJPO,Inhibitory activity of compound against conversion of [1-14C]-archidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
209,16474,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),B,,,,,,,,,11134,H,8,Autocuration,9,ORIGINAL,1,,CHEMBL615243,2006-04-20 15:42:47,admin_actype,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
210,1630,Inhibitory activity against human platelet 12-lipoxygenase,B,,,,,,,,,11134,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615244,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against human platelet 12-lipoxygenase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
211,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,B,,,,,,,,,11134,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615245,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against human platelet 12-lipoxygenase was evaluated,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
212,16474,% inhibition against human platelet 12-lipoxygenase (12-HLO),B,,,,,,,,,11134,H,8,Autocuration,10,ORIGINAL,1,,CHEMBL615246,2006-04-20 15:43:24,admin_actype,% inhibition against human platelet 12-lipoxygenase (12-HLO),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
213,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,B,,,,,,,,,11134,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615247,2011-01-19 17:04:36,LJB Desc Spelling,Inhibitory activity of the compound against human platelet 12-lipoxygenase was evaluated at 100 uM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
214,16474,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,B,,,,,,,,,11134,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615248,2006-04-20 15:43:24,admin_actype,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
215,10091,Inhibitory activity towards porcine 12-lipoxygenase,B,,,,,,,,,11601,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615249,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound towards porcine 12-lipoxygenase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
216,11966,Tested for inhibition against porcine 12-LO,B,,,,,,,,,11601,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615250,2006-04-20 15:42:47,admin_actype,Tested for inhibition against porcine 12-LO,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
217,951,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,B,,,,,,,,,12052,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615251,2006-11-28 16:58:32,BautoJPO,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin upto a concentration of 10microM; NE means No effect,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
218,10997,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,B,,,,,,Plasma,,,12052,H,8,Autocuration,10,ORIGINAL,1,,CHEMBL615252,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against 12-lipoxygenase in rat platelet rich plasma,,,,,,,BAO_0000366,1969,,,CLD0,0,0,CLD0,
219,10193,In vitro inhibition of rat platelet 12-lipoxygenase,B,,,,,,,,,12052,H,8,Expert,24,ORIGINAL,1,,CHEMBL828340,2011-01-19 15:40:47,LJB Desc Spelling,Invitro inhibitory activity against rat platelet 12-lipoxygenase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
220,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615253,2011-01-19 17:05:01,LJB Desc Spelling,Invitro inhibitory activity against rat platelet 12-lipoxygenase at 10 microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
221,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,B,,,,,,,,,12052,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615254,2011-01-19 17:05:09,LJB Desc Spelling,Invitro inhibitory activity against rat platelet 12-lipoxygenase at 100 microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
222,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,B,,,,,,,,,12052,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615255,2011-01-19 17:05:05,LJB Desc Spelling,Invitro inhibitory activity against rat platelet 12-lipoxygenase at 30 microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
223,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615256,2011-01-19 17:04:42,LJB Desc Spelling,Invitro inhibitory activity against rat platelet 12-lipoxygenaseat 10 microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
224,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase,B,,,,,,,,,12052,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615257,2011-01-19 15:40:49,LJB Desc Spelling,Invitro inhibitory activity against rat platelet 12-lipoxygenase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
225,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,B,,,,,,,,,12052,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615258,2011-01-19 17:05:06,LJB Desc Spelling,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 microM.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
226,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,F,,,Homo sapiens,9606,,,41M,,80007,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615259,2013-02-14 14:00:47,set cell-type from tid,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,,,,,,621,BAO_0000219,,,,CLD0,0,0,CLD0,
227,12989,In vitro antitumor activity against 41M cell line.,F,,,Homo sapiens,9606,,,41M,,80007,N,1,Expert,37,ORIGINAL,1,,CHEMBL615260,2013-02-14 14:00:47,set cell-type from tid,In vitro antitumor activity against 41M cell line was determined,,,,,,621,BAO_0000219,,,,CLD0,0,0,CLD0,
228,16745,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,F,,,Homo sapiens,9606,,,41M,,80007,N,1,Intermediate,9,ORIGINAL,1,,CHEMBL615261,2013-02-14 14:00:47,set cell-type from tid,cytotoxicity aganist 41M cells incubated for 24h in MTT assay.,,,,,,621,BAO_0000219,,,,CLD0,0,0,CLD0,
229,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,F,,,Homo sapiens,9606,,,41M/CDDP,,80007,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615262,2013-02-14 14:00:47,set cell-type from tid,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
230,12989,In vitro antitumor activity against 41McisR cell line.,F,,,Homo sapiens,9606,,,41McisR,,80007,N,1,Expert,37,ORIGINAL,1,,CHEMBL615263,2013-02-14 14:00:47,set cell-type from tid,In vitro antitumor activity against 41McisR cell line was determined,,,,,,5599,BAO_0000219,,,,CLD0,0,0,CLD0,
231,12989,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,F,,,Homo sapiens,9606,,,41McisR,,80007,N,1,Expert,25,ORIGINAL,1,,CHEMBL838393,2013-12-05 18:44:55,george_spelling,Resistant factor of the compound was determined between IC50 of resistant line to that of 41McisR cell line,,,,,,5599,BAO_0000219,,,,CLD0,0,0,CLD0,
232,16745,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,F,,,Homo sapiens,9606,,,41McisR,,80007,N,1,Intermediate,9,ORIGINAL,1,,CHEMBL615264,2013-02-14 14:00:47,set cell-type from tid,cytotoxicity aganist 41McisR cells incubated for 24h in MTT assay,,,,,,5599,BAO_0000219,,,,CLD0,0,0,CLD0,
233,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),B,,,Homo sapiens,9606,,,,,84,D,9,Expert,1,ORIGINAL,1,,CHEMBL615265,2006-04-20 15:42:47,admin_actype,Inhibitory activity of the compound against 5'-inosine monophosphate dehydrogenase type I (IMPDH I),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
234,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),B,,,Homo sapiens,9606,,,,,68,D,9,Expert,13,ORIGINAL,1,,CHEMBL615266,2006-04-20 15:42:47,admin_actype,Inhibitory activity of the compound against 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
235,6226,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),B,,,,,,,,,68,H,8,Expert,25,ORIGINAL,1,,CHEMBL615267,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
236,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,B,,,,,,,,,10201,H,8,Expert,10,ORIGINAL,1,,CHEMBL615268,2006-04-20 15:43:45,admin_actype,Equilibrium dissociation constant of the compound towards human 5'-methylthioadenosine phosphorylase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
237,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,B,,,,,,,,,10201,H,8,Expert,6,ORIGINAL,1,,CHEMBL615269,2006-04-20 15:43:45,admin_actype,Equilibrium dissociation constant of the compound towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
238,17855,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,B,,,,,,,,,10201,H,8,Expert,16,ORIGINAL,1,,CHEMBL615270,2006-04-20 15:43:45,admin_actype,Initial dissociation constant of the compound towards human 5'-methylthioadenosine phosphorylase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
239,10413,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615271,2006-11-28 16:58:32,BautoJPO,"Evaluated for inhibitory activitie on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100microM",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
240,10413,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",B,,,Escherichia coli,562,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615272,2006-11-23 12:25:28,BautoJPO,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1mM; NT=Not tested",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
241,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",B,,,Escherichia coli,562,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615103,2006-11-28 16:58:32,BautoJPO,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1mM; NT=Not tested",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
242,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",B,,,Escherichia coli,562,,,,,11303,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615104,2006-11-23 12:25:28,BautoJPO,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1mM;NT=Not tested",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
243,10413,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615105,2006-11-28 16:58:32,BautoJPO,"Evaluated for inhibitory activitie on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100microM",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
244,10413,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL872866,2006-11-23 12:26:18,BautoJPO,"Evaluated for inhibitory activitie on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100microM",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
245,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615106,2013-12-05 18:44:55,george_spelling,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase  (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
246,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615107,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
247,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615108,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
248,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615109,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
249,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615110,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
250,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL840105,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
251,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615111,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
252,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615112,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
253,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615113,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
254,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615114,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
255,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615115,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
256,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615116,2006-04-20 15:43:41,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
257,7323,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",B,,,,,,,,,11303,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615698,2013-12-19 14:25:23,george_spelling,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase ,competitive against (+)-L-5,10-methenyltetrahydrofolate",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
258,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823,,,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL615699,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
259,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",B,,,Sus scrofa,9823,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615700,2006-04-20 15:43:24,admin_actype,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
260,13750,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,B,,,Saccharomyces cerevisiae,4932,,,,,100249,H,8,Expert,12,ORIGINAL,1,,CHEMBL615701,2006-04-20 15:42:47,admin_actype,Compound was evaluated for inhibition of 5-Desaturase Inhibitor (an Enzyme Late in the Biosynthesis of the Fungal Sterol Ergosterol).,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
261,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,8,ORIGINAL,1,,CHEMBL615702,2004-10-31 12:48:03,admin,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
262,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,9,ORIGINAL,1,,CHEMBL615703,2004-10-31 12:48:03,admin,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
263,7662,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,7,ORIGINAL,1,,CHEMBL615704,2004-10-31 12:48:03,admin,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
264,12211,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",F,,,,,,,,,104698,H,6,Autocuration,14,ORIGINAL,1,,CHEMBL615705,2006-04-20 15:43:22,admin_actype,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
265,12211,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",F,,,,,,,,,104698,H,6,Autocuration,1,ORIGINAL,1,,CHEMBL615706,2006-04-20 15:43:22,admin_actype,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
266,12211,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,F,,,Cavia porcellus,10141,,Ileum,,,20033,D,9,Intermediate,12,ORIGINAL,1,,CHEMBL615707,2013-03-07 16:01:20,H2D_target_reset,Relative ability of the compound to increase cholinergically mediated contractions in isolated ileum of guinea pig,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
267,12211,Stimulatory activity of intragastric pressure was tested in the rat,F,,,,,,,,,10623,H,8,Expert,9,ORIGINAL,1,,CHEMBL615708,2006-04-20 15:42:35,admin_actype,Stimulatory activity of intragastric pressure was tested in the rat,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
268,15453,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,B,,,,,,,,,121,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615709,2004-10-31 12:48:03,spell,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetin as a radioligand.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
269,11884,Dose to reduce neuronal firing against 5-HT cells in rats (iv),F,,,Rattus norvegicus,10116,,,,,22221,N,1,Autocuration,5,ORIGINAL,1,,CHEMBL615710,2006-04-20 15:42:35,admin_actype,Dose to reduce neuronal firing against 5-HT cells in rats (iv),,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
270,7185,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,F,,,,,,,,,12688,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615711,2011-06-09 17:19:30,F_type_fix,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
271,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,B,,,Homo sapiens,9606,,,,,121,D,9,Expert,14,ORIGINAL,1,,CHEMBL615712,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was evaluated at 5-HT reuptake site labeled with [3H]-paroxetine,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
272,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,B,,,Homo sapiens,9606,,,,,121,D,9,Expert,1,ORIGINAL,1,,CHEMBL836325,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was evaluated at 5-HT reuptake site labeled with [3H]-paroxetine; No data,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
273,11863,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,F,,,,,,,,,12198,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615713,2011-01-19 17:05:01,LJB Desc Spelling,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
274,11863,Inhibition constant of high-affinity 5-HT uptake,B,,,,,,,,,12198,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615714,2006-04-20 15:43:45,admin_actype,Inhibition constant of high-affinity 5-HT uptake,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
275,11863,Michaelis-Menten constant was reported for high affinity transport of 5-HT,F,,,,,,,,,12198,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615715,2013-12-05 18:11:28,george_spelling,Michealis Menton constant was reported for high affinity transport of 5-HT,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
276,11863,Maximum rate was determined for high affinity transport of 5-HT,F,,,,,,,,,12198,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615716,2004-10-31 12:48:03,admin,Maximum rate was determined for high affinity transport of 5-HT,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
277,4639,Compound was tested for agonistic activity against 5-HT uptake,F,,,,,,,,,104714,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615717,2011-06-09 17:19:30,F_type_fix,Compound was tested for agonistic activity against 5-HT uptake,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
278,15796,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,B,,,,,,Frontal cortex,,,10577,H,8,Expert,11,ORIGINAL,1,,CHEMBL881818,2006-04-20 15:42:47,admin_actype,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay.,,,,,,,BAO_0000221,1870,,,CLD0,0,0,CLD0,
279,15796,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,B,,,Bos taurus,9913,,,,,105,H,8,Expert,11,ORIGINAL,1,,CHEMBL884540,2006-04-20 15:42:47,admin_actype,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
280,12801,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,B,,,Rattus norvegicus,10116,,,,,104744,D,5,Autocuration,9,ORIGINAL,1,,CHEMBL615718,2006-04-20 15:42:47,admin_actype,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]-5-HT as radioligand,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
281,12801,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,B,,,,,,,,,104744,H,4,Autocuration,2,ORIGINAL,1,,CHEMBL615719,2006-04-20 15:42:47,admin_actype,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]-5-HT as radioligand,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
282,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,B,,,,,,,,Membrane,104744,H,4,Autocuration,2,ORIGINAL,1,,CHEMBL615720,2006-11-23 12:25:28,BautoJPO,Percent inhibition of binding of 3.0 nM [3H-5HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
283,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,B,,,,,,,,Membrane,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615721,2006-11-28 16:58:32,BautoJPO,Percent inhibition of binding of 3.0 nM [3H-5HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
284,11963,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,Cerebral cortex,,,104744,H,4,Autocuration,5,ORIGINAL,1,,CHEMBL615722,2006-11-28 16:58:32,BautoJPO,Displacement of binding of 3H-5HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
285,11701,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,F,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615723,2010-10-26 17:10:29,SQL-abbr-desc,Dose of the compound required to reduce neuronal firing of 5-HT1A cells by 50%,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
286,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615724,2006-11-28 16:58:32,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-5-HT(2nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
287,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615725,2006-11-23 12:25:28,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-DPAT(1nM) binding to 5-HT1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
288,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615726,2006-11-28 16:58:32,BautoJPO,Compound was tetsed in vitro for the inhibition of [3H]-DPAT(1nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
289,16394,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615727,2006-04-20 15:43:22,admin_actype,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
290,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,F,,,Cavia porcellus,10141,,,,,105570,D,9,Intermediate,2,ORIGINAL,1,,CHEMBL615728,2010-10-26 17:10:29,SQL-abbr-desc,Effect of the compound on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
291,15779,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,279,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL857971,2006-11-23 12:25:29,BautoJPO,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
292,15363,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615729,2006-11-28 16:58:32,BautoJPO,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
293,15363,Efficacy against 5-hydroxytryptamine 2A receptor,F,,,Rattus norvegicus,10116,,,,,12687,D,9,Expert,8,ORIGINAL,1,,CHEMBL615730,2006-04-27 00:00:00,ylight,Efficacy of the compound at 5-hydroxytryptamine 2A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
294,15329,Intrinsic activity towards 5-HT2A receptor of rat tail artery,F,,,,,,Tail,,,12687,H,8,Expert,6,ORIGINAL,1,,CHEMBL615731,2005-03-17 00:00:00,rmyers,Intrinsic activity of compound towards 5-HT2A receptor of rat tail artery,,,,,,,BAO_0000221,2415,,,CLD0,0,0,CLD0,
295,15329,Relative potency towards 5-HT2A receptor of rat tail artery,F,,,,,,Tail,,,12687,H,8,Expert,6,ORIGINAL,1,,CHEMBL615732,2005-03-17 00:00:00,rmyers,Relative potency of the compound towards 5-HT2A receptor of rat tail artery,,,,,,,BAO_0000221,2415,,,CLD0,0,0,CLD0,
296,15329,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,F,,,,,,Artery,,,12687,H,8,Expert,25,ORIGINAL,1,,CHEMBL615733,2006-04-20 15:44:24,admin_actype,Effectiveness of compound in blocking 5-HT2A receptor-mediated contractions of rat tail artery,,,,,,,BAO_0000221,1637,,,CLD0,0,0,CLD0,
297,15329,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,F,,,,,,Tail,,,12687,H,8,Expert,6,ORIGINAL,1,,CHEMBL615734,2006-04-20 15:44:24,admin_actype,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,,,,,,,BAO_0000221,2415,,,CLD0,0,0,CLD0,
298,15329,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,F,,,,,,Tail,,,12687,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615735,2004-10-31 12:48:03,admin,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,,,,,,,BAO_0000221,2415,,,CLD0,0,0,CLD0,
299,15329,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,F,,,,,,Tail,,,12687,H,8,Expert,15,ORIGINAL,1,,CHEMBL615736,2005-03-17 00:00:00,rmyers,Effectiveness of compound in blocking 5-HT2A receptor-mediated contractions of rat tail artery,,,,,,,BAO_0000221,2415,,,CLD0,0,0,CLD0,
300,273,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141,,Ileum,,,20033,D,9,Intermediate,1,ORIGINAL,1,,CHEMBL615737,2013-03-07 16:01:20,H2D_target_reset,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
301,273,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),F,,,Cavia porcellus,10141,,Ileum,,,20033,D,9,Intermediate,7,ORIGINAL,1,,CHEMBL615738,2013-03-07 16:01:20,H2D_target_reset,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
302,273,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141,,Ileum,,,20033,D,9,Intermediate,3,ORIGINAL,1,,CHEMBL615739,2013-03-07 16:01:20,H2D_target_reset,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
303,12092,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,B,,,,,,,,,10623,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615278,2011-01-19 16:43:36,LJB Desc Spelling,The binding affinity of the compound was measured on 5-hydroxytryptamine 4 receptor using [3H] GR113808 as radioligand.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
304,1317,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,F,,,Rattus norvegicus,10116,,,,,10623,D,9,Expert,7,ORIGINAL,1,,CHEMBL615279,2006-05-02 00:00:00,ylight,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
305,12409,Binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,ORIGINAL,1,,CHEMBL615280,2006-04-20 15:44:08,admin_actype,Tested for its binding affinity against the 5-hydroxytryptamine 4 receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
306,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,B,,,Gallus gallus,9031,,,,,22226,U,0,Autocuration,5,ORIGINAL,1,,CHEMBL615281,2010-10-26 17:10:29,SQL-abbr-desc,Relative competitive index values of the compound for binding to 25-OH-D3-1-hydroxylase of chick intestine,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
307,11126,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,F,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615282,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory effect of the compound (10E-6M) on the 25-OH-D3-1-hydroxylase activity,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
308,11126,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,F,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615283,2010-10-26 17:10:29,SQL-abbr-desc,25-OH-D3-1-hydroxylase activity of the compound (10E-6M) was measured as %control,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
309,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,B,,,Homo sapiens,9606,,,HL-60,,80156,N,1,Autocuration,1,ORIGINAL,1,,CHEMBL615284,2010-10-26 17:10:29,PM_24_MAY_2016,Relative competitive index values of the compound for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,,,,,,649,BAO_0000219,,,,CLD0,0,0,CLD0,
310,11126,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,B,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL615285,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory effect of the compound (10E-6M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
311,11126,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,B,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL615286,2010-10-26 17:10:29,SQL-abbr-desc,25-hydroxyvitamin D3-1-hydroxylase activity of the compound (10E-6M) was measured as %control,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
312,17807,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,B,,,Homo sapiens,9606,,,Oocyte,,104703,D,7,Autocuration,1,ORIGINAL,1,,CHEMBL615287,2006-11-28 17:04:09,BautoJPO,Tested for the displacement of [3H]Ro 15-1788 binding from recombinant human GABA-A alpha1beta3gamma2 receptor subtype,,,,,,1758,BAO_0000219,,,,CLD0,0,0,CLD0,
313,16575,Chymotryptic inhibitory activity against 26S proteasome,F,,,,,,,,,100256,S,2,Intermediate,1,ORIGINAL,1,,CHEMBL615288,2006-04-20 15:42:47,admin_actype,Chymotryptic inhibitory activity against 26S proteasome,,,,,,,BAO_0000220,,,,CLD0,0,0,CLD0,
314,15407,Inhibitory activity against 26S proteasome degradation of IkB,B,,,,,,,,,100256,S,2,Intermediate,1,ORIGINAL,1,,CHEMBL615289,2006-04-20 15:43:45,admin_actype,Inhibitory activity against 26S proteasome degradation of IkB,,,,,,,BAO_0000220,,,,CLD0,0,0,CLD0,
315,10797,In vitro inhibition of 2780/DOX ovarian cancer cell line,F,,,Homo sapiens,9606,,,A2780,,81034,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615290,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibition of 2780/DOX ovarian cancer cell line,,,,,,478,BAO_0000219,,,,CLD0,0,0,CLD0,
316,10797,In vitro inhibition of 2780/S ovarian cancer cell line,F,,,Homo sapiens,9606,,,A2780,,81034,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL884522,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibition of 2780/S ovarian cancer cell line,,,,,,478,BAO_0000219,,,,CLD0,0,0,CLD0,
317,3469,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,F,,,Homo sapiens,9606,,,A2780 ADR,,22226,U,0,Autocuration,10,ORIGINAL,1,,CHEMBL615291,2004-10-31 12:48:03,admin,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,,,,,,5594,BAO_0000219,,,,CLD0,0,0,CLD0,
318,16037,Association constant for binding to AATT 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,3,ORIGINAL,1,,CHEMBL615292,2004-10-31 12:48:03,admin,Association constant for binding to AATT 28-mer AATT hairpin,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
319,16037,Kinetically Defined Association Constant for 28-mer AATT hairpin.,B,,,,,,,,,22222,M,3,Intermediate,3,ORIGINAL,1,,CHEMBL615293,2004-10-31 12:48:03,admin,Kinetically Defined Association Constant for 28-mer AATT hairpin.,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
320,16037,Reaction Rate Parameter for 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,3,ORIGINAL,1,,CHEMBL615294,2004-10-31 12:48:03,admin,Reaction Rate Parameter for 28-mer AATT hairpin,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
321,16037,Reaction Rate Parameter for 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,3,ORIGINAL,1,,CHEMBL615295,2004-10-31 12:48:03,admin,Reaction Rate Parameter for 28-mer AATT hairpin,,,,,,,BAO_0000225,,,,CLD0,0,0,CLD0,
322,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),F,,,Homo sapiens,9606,,,,,22221,N,1,Autocuration,14,ORIGINAL,1,,CHEMBL825021,2004-10-31 12:48:03,admin,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
323,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),F,,,Homo sapiens,9606,,,,,22221,N,1,Autocuration,14,ORIGINAL,1,,CHEMBL615296,2004-10-31 12:48:03,admin,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
324,16524,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,F,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL615297,2006-04-20 15:42:47,admin_actype,Inhibitory concentration of the compound was determined by single cycle replication assay using envelope deficient HIV-1,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
325,16758,Cytotoxicity against cell line 2SC/20 determined by MTT test,F,,,Cricetulus griseus,10029,,,,,22221,N,1,Autocuration,2,ORIGINAL,1,,CHEMBL615298,2006-04-20 15:42:47,admin_actype,Cytotoxicity against cell line 2SC/20 determined by MTT test,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
326,16758,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,F,,,Cricetulus griseus,10029,,,,,22221,N,1,Autocuration,3,ORIGINAL,1,,CHEMBL615299,2006-04-20 15:42:47,admin_actype,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
327,16758,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,F,,,Cricetulus griseus,10029,,,,,22221,N,1,Autocuration,1,ORIGINAL,1,,CHEMBL615300,2006-04-20 15:42:47,admin_actype,Inhibitory concentration against the growth of 2SC/20 cell line after 72 h of drug exposure by MTTtest,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
328,14360,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,B,,,,,,,,,241,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615301,2010-10-26 16:15:59,SQL-abbr-desc,Binding affinity of the compound was tested on 3 beta-hydroxysteroid dehydrogenase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
329,14360,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,B,,,Homo sapiens,9606,,,,,241,D,9,Expert,13,ORIGINAL,1,,CHEMBL615302,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was tested on 3 beta-hydroxysteroid dehydrogenase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
330,9964,Selectivity ratio of ID50 in liver and heart,B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,11,ORIGINAL,1,,CHEMBL615303,2006-03-27 00:00:00,ylight,"Selectivity, ratio between relative ID50 in liver and heart",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
331,9964,"Selectivity, ratio of relative ID50 in liver and heart",B,,,,,,,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615304,2004-10-31 12:48:03,admin,"Selectivity, ratio of relative ID50 in liver and heart",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
332,9964,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,B,,,,,,,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615305,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
333,9964,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,Heart,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615306,2010-10-26 17:10:29,SQL-abbr-desc,"Binding affinity of the compound to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000218,948,,,CLD0,0,0,CLD0,
334,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,Liver,,,12132,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615307,2010-10-26 17:10:29,SQL-abbr-desc,"Binding affinity of the compound to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000218,2107,,,CLD0,0,0,CLD0,
335,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,In vivo,,,,,Liver,,,12132,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615308,2011-01-19 15:57:56,LJB Desc Spelling,"Binding affinity of the compound to the receptor was determined in nuclei of liver invivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000218,2107,,,CLD0,0,0,CLD0,
336,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",F,In vivo,,,,,Liver,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615309,2011-01-19 15:57:56,LJB Desc Spelling,"Binding affinity of the compound to the receptor was determined in nuclei of liver invivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000218,2107,,,CLD0,0,0,CLD0,
337,9964,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",B,,,,,,Liver,,,22226,U,0,Autocuration,28,ORIGINAL,1,,CHEMBL615310,2004-11-24 00:00:00,rick,"Binding affinity of the compound to the receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000221,2107,,,CLD0,0,0,CLD0,
338,9964,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,B,,,,,,Liver,,,12132,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615311,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,,,,,,,BAO_0000221,2107,,,CLD0,0,0,CLD0,
339,9964,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",B,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,17,ORIGINAL,1,,CHEMBL615312,2005-02-23 00:00:00,mdocherty,"In vitro binding affinity of the compound to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
340,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,B,,,,,,,,,12132,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615313,2010-10-26 17:10:29,SQL-abbr-desc,In vitro binding affinity of the compound to the receptor was determined in isolated nuclei of heart relative to T3,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
341,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,F,,,,,,,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615314,2010-10-26 17:10:29,SQL-abbr-desc,In vitro binding affinity of the compound to the receptor was determined in isolated nuclei of heart relative to T3,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
342,9964,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615315,2010-10-26 17:10:29,SQL-abbr-desc,"Binding affinity of the compound to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
343,9964,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,13,ORIGINAL,1,,CHEMBL615316,2006-11-23 12:25:28,BautoJPO,"Binding affinity of the compound to the receptor was determined in nuclei of heart invivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
344,9964,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,B,In vivo,,,,,Heart,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615317,2011-01-19 15:57:55,LJB Desc Spelling,Binding affinity of the compound to the receptor was determined in nuclei of heart invivo 1 hour after intravenous administration relative to T3,,,,,,,BAO_0000218,948,,,CLD0,0,0,CLD0,
345,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,Liver,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615318,2010-10-26 17:10:29,SQL-abbr-desc,"Binding affinity of the compound to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000218,2107,,,CLD0,0,0,CLD0,
346,9964,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,13,ORIGINAL,1,,CHEMBL615319,2006-01-13 00:00:00,ylight,"Binding affinity of the compound to the receptor was determined in nuclei of liver invivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
347,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615320,2010-10-26 17:10:29,SQL-abbr-desc,"In vitro binding affinity of the compound to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
348,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",F,,,,,,,,,12132,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615321,2010-10-26 17:10:29,SQL-abbr-desc,"In vitro binding affinity of the compound to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
349,3796,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,15,ORIGINAL,1,,CHEMBL615322,2006-11-28 16:58:32,BautoJPO,"Compound was evaluated in vitro for inhibition of competitive binding of [125I]-L-T3 to the rat hepatic 3,5,3'- triiodo-L-thyronine receptor",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
350,4251,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,B,,,Escherichia coli,562,,,,,19690,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615323,2006-12-04 18:06:22,BautoJPO,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from E.coli,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
351,4251,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,B,,,Escherichia coli,562,,,,,19690,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615407,2006-12-04 18:06:06,BautoJPO,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from E.coli,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
352,4251,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,B,,,Escherichia coli,562,,,,,19690,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL857267,2010-10-26 17:10:29,SQL-abbr-desc,Kinetics of the compound expressed as Michealis-Menton constant against Co2+ form of 3-dehydroquinate synthase purified from E.coli,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
353,4251,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,B,,,Escherichia coli,562,,,,,19690,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615408,2010-10-26 17:10:29,SQL-abbr-desc,Kinetics of the compound expressed as Michealis-Menton constant against Zn2+ form of 3-dehydroquinate synthase purified from E.coli,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
354,166,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,B,,,,,,,,,19690,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615409,2006-04-20 15:43:24,admin_actype,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
355,17861,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615410,2006-04-20 15:43:45,admin_actype,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
356,166,Inhibition constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615411,2006-04-20 15:43:45,admin_actype,Inhibition constant of the compound was determined against 3-dehydroquinate synthase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
357,166,Association rate constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615412,2004-10-31 12:48:03,admin,Association rate constant of the compound was determined against 3-dehydroquinate synthase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
358,166,Rate constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615413,2004-10-31 12:48:03,admin,Rate constant of the compound was determined against 3-dehydroquinate synthase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
359,3548,Inhibitory activity against fuc-TVII,B,,,,,,,,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL615414,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against fuc-TVII,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
360,9877,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615415,2006-11-28 16:58:32,BautoJPO,Ability of compound (2.5microM) to inhibit the activity of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14c]mevalonate in rat liver microsomes,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
361,9877,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615416,2006-11-23 12:25:28,BautoJPO,Ability of compound (2500microM) to inhibit the activity of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14c]mevalonate in rat liver microsomes,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
362,9877,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615417,2006-11-28 16:58:32,BautoJPO,Ability of compound (250microM) to inhibit the activity of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14c]mevalonate in rat liver microsomes,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
363,9877,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615418,2006-11-28 16:58:32,BautoJPO,Ability of compound (25microM) to inhibit the activity of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14c]mevalonate in rat liver microsomes,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
364,9877,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615419,2011-01-19 17:05:12,LJB Desc Spelling,Ability of compound at 0 uM to inhibit the activity of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14c]mevalonate in rat liver microsomes,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
365,9877,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,7,ORIGINAL,1,,CHEMBL615420,2006-04-20 15:42:47,admin_actype,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
366,9877,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615421,2006-11-23 12:25:28,BautoJPO,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250uM,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
367,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615422,2006-11-28 16:58:32,BautoJPO,Percentage inhibition of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0uM,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
368,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615423,2006-11-28 16:58:32,BautoJPO,Percentage inhibition of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5uM,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
369,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL872868,2006-11-23 12:25:27,BautoJPO,Percentage inhibition of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500uM,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
370,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,B,,,Rattus norvegicus,10116,,Liver,,Microsome,12236,D,9,Autocuration,1,ORIGINAL,1,,CHEMBL615424,2006-11-23 12:25:28,BautoJPO,Percentage inhibition of 3hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25uM,,,,,,,BAO_0000251,2107,,,CLD0,0,0,CLD0,
371,3003,Inhibitory activity against 3-phosphoglycerate kinase.,B,,,,,,,,,104832,H,4,Autocuration,37,ORIGINAL,1,,CHEMBL825022,2006-04-20 15:42:47,admin_actype,Inhibitory activity of the compound aganist 3- phosphoglycerate kinase was determined,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
372,3003,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,B,,,,,,,,,104832,H,4,Autocuration,8,ORIGINAL,1,,CHEMBL615425,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound was evaluated towards 3-phosphoglycerate kinase at 37 degrees centigrade in 0.1 m NaCl P.H 7.1,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
373,3003,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",B,,,,,,,,,104832,H,4,Autocuration,8,ORIGINAL,1,,CHEMBL615426,2010-10-26 17:10:29,SQL-abbr-desc,"Michaelis-menten constant of the compound with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
374,17185,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,B,,,Homo sapiens,9606,,,,,10612,D,9,Expert,2,ORIGINAL,1,,CHEMBL615427,2006-11-28 16:58:32,BautoJPO,"Inhibitory mean % of control activity of the compound (10microM) in presence of 10microM ATP against human 3-phosphoinositide-dependent
protein kinase 1 was determined",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
375,6072,Cytotoxicity on 3677 melanoma cells,F,,,Homo sapiens,9606,,,3677 melanoma cell line,,80616,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615428,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity of the compound on 3677 melanoma cells,,,,,,844,BAO_0000219,,,,CLD0,0,0,CLD0,
376,6072,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,F,,,Homo sapiens,9606,,,3677 melanoma cell line,,80616,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615429,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity of the compound on 3677 melanoma cells in combination with L-49-sFv-bL,,,,,,844,BAO_0000219,,,,CLD0,0,0,CLD0,
377,5018,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,F,,,Mus musculus,10090,,,MC-38,,80617,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615430,2013-02-14 14:00:47,set cell-type from tid,Antitumor activity of the compound was determined against Mouse colon 38 at 500 ug/disk in disk diffusion assay,,,,,,700,BAO_0000219,,,,CLD0,0,0,CLD0,
378,2852,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,F,,,Homo sapiens,9606,,,,,22226,U,0,Intermediate,1,ORIGINAL,1,,CHEMBL615431,2013-02-14 14:00:47,set cell-type from tid,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell line,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
379,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,F,,,,,,,B16,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615432,2010-10-26 17:10:29,SQL-abbr-desc,In vivo antitumor activity of the compound against 3B131 intraperitoneally implated B16 melanoma cells; NT= Not tested,,,,,,798,BAO_0000218,,,,CLD0,0,0,CLD0,
380,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,F,,,,,,,B16,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL615433,2010-10-26 17:10:29,SQL-abbr-desc,In vivo antitumor activity of the compound against 3B131 intraperitoneally implated B16 melanoma cells; reproducible significant activity.,,,,,,798,BAO_0000218,,,,CLD0,0,0,CLD0,
381,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,F,,,Human rhinovirus 14,12131,,,,,12464,H,8,Expert,12,ORIGINAL,1,,CHEMBL615434,2012-03-20 11:41:11,F-type_fix,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
382,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,F,,,Human rhinovirus sp.,169066,,,,,50085,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615435,2012-03-20 11:41:11,F-type_fix,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
383,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,F,,,human rhinovirus type 14,169066,,,,,50679,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615436,2012-03-20 11:41:11,F-type_fix,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
384,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,F,,,human rhinovirus type 14,169066,,,,,50679,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615437,2012-03-20 11:41:11,F-type_fix,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
385,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131,,,,,12464,H,8,Expert,1,ORIGINAL,1,,CHEMBL615438,2012-03-20 11:41:11,F-type_fix,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
386,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131,,,,,12464,H,8,Expert,1,ORIGINAL,1,,CHEMBL615439,2012-03-20 11:41:11,F-type_fix,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
387,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131,,,,,12464,H,8,Expert,15,ORIGINAL,1,,CHEMBL615440,2012-03-20 11:41:11,F-type_fix,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
388,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,F,,,Human rhinovirus 14,12131,,,,,12464,H,8,Expert,1,ORIGINAL,1,,CHEMBL615441,2012-03-20 11:41:11,F-type_fix,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
389,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,F,,,Enterovirus,12059,,,,,50665,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615641,2012-03-20 11:41:11,F-type_fix,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
390,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,F,,,Enterovirus,12059,,,,,50665,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL872065,2012-03-20 11:41:11,F-type_fix,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
391,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,F,,,Enterovirus,12059,,,,,50665,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL825023,2012-03-20 11:41:11,F-type_fix,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
392,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,F,,,Enterovirus,12059,,,,,50665,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615642,2012-03-20 11:41:11,F-type_fix,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
393,13748,Inhibition of human rhinovirus 3C protease,B,,,Human rhinovirus B,147712,,,,,12464,H,8,Expert,24,ORIGINAL,1,,CHEMBL615643,2006-04-20 15:43:45,admin_actype,Inhibitory activity of compound towards human rhinovirus 3C protease,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
394,17699,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,B,,,Homo sapiens,9606,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615644,2004-10-31 12:48:03,admin,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
395,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),F,,,Mus musculus,10090,,,3EM 37,,80619,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615645,2013-02-14 14:00:47,set cell-type from tid,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),,,,,,833,BAO_0000218,,,,CLD0,0,0,CLD0,
396,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),F,,,Mus musculus,10090,,,3EM 37,,80619,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615646,2013-02-14 14:00:47,set cell-type from tid,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),,,,,,833,BAO_0000218,,,,CLD0,0,0,CLD0,
397,7145,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),F,,,Mus musculus,10090,,,3EM 37,,80619,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615647,2013-02-14 14:00:47,set cell-type from tid,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),,,,,,833,BAO_0000218,,,,CLD0,0,0,CLD0,
398,7145,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),F,,,Mus musculus,10090,,,3EM 37,,80619,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615648,2013-02-14 14:00:47,set cell-type from tid,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),,,,,,833,BAO_0000218,,,,CLD0,0,0,CLD0,
399,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,F,,,Mus musculus,10090,,,3EM 37,,80619,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615649,2013-02-14 14:00:47,set cell-type from tid,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,,,,,,833,BAO_0000218,,,,CLD0,0,0,CLD0,
400,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,F,,,Mus musculus,10090,,,3EM 37,,80619,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615650,2013-02-14 14:00:47,set cell-type from tid,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,,,,,,833,BAO_0000218,,,,CLD0,0,0,CLD0,
401,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,F,,,Mus musculus,10090,,Lung,3LL cell line,,80620,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615651,2013-02-14 14:00:47,set cell-type from tid,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mkp/b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,,,,,847,BAO_0000218,2048,,,CLD0,0,0,CLD0,
402,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,F,,,Mus musculus,10090,,Lung,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615652,2013-02-14 14:00:47,set cell-type from tid,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,,,,,847,BAO_0000218,2048,,,CLD0,0,0,CLD0,
403,5325,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,F,,,Mus musculus,10090,,Lung,3LL cell line,,80620,N,1,Expert,20,ORIGINAL,1,,CHEMBL615653,2013-02-14 14:00:47,set cell-type from tid,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested,,,,,,847,BAO_0000218,2048,,,CLD0,0,0,CLD0,
404,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615654,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
405,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615655,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
406,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL825024,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
407,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615656,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
408,16169,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615657,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
409,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615658,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
410,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615659,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
411,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615660,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
412,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615661,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
413,16169,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615662,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
414,16169,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,8,ORIGINAL,1,,CHEMBL615663,2013-02-14 14:00:47,set cell-type from tid,Effect of the compound on the growth of 3LL cells by DFMO pretreatment at 48 h incubation,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
415,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,11,ORIGINAL,1,,CHEMBL615664,2013-02-14 14:00:47,set cell-type from tid,Effect of the compound on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
416,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,11,ORIGINAL,1,,CHEMBL615665,2013-02-14 14:00:47,set cell-type from tid,Effect of the compound on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
417,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615666,2013-02-14 14:00:47,set cell-type from tid,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 microM dose,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
418,16169,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615667,2013-02-14 14:00:47,set cell-type from tid,putrescine levels in 3LL cells after the treatment of 1 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
419,16169,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615668,2013-02-14 14:00:47,set cell-type from tid,putrescine levels in 3LL cells after the treatment of 10 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
420,16169,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615669,2013-02-14 14:00:47,set cell-type from tid,putrescine levels in 3LL cells after the treatment of 250 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
421,16169,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615670,2013-02-14 14:00:47,set cell-type from tid,putrescine levels in 3LL cells after the treatment of 50 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
422,16169,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL836739,2013-02-14 14:00:47,set cell-type from tid,spermidine levels in 3LL cells after the treatment of 1 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
423,16169,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615671,2013-02-14 14:00:47,set cell-type from tid,spermidine levels in 3LL cells after the treatment of 10 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
424,16169,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615672,2013-02-14 14:00:47,set cell-type from tid,spermidine levels in 3LL cells after the treatment of 250 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
425,16169,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615791,2013-02-14 14:00:47,set cell-type from tid,spermidine levels in 3LL cells after the treatment of 50 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
426,16169,spermine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615792,2013-02-14 14:00:47,set cell-type from tid,spermine levels in 3LL cells after the treatment of 1 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
427,16169,spermine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615793,2013-02-14 14:00:47,set cell-type from tid,spermine levels in 3LL cells after the treatment of 10 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
428,16169,spermine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615794,2013-02-14 14:00:47,set cell-type from tid,spermine levels in 3LL cells after the treatment of 250 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
429,16169,spermine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090,,,3LL cell line,,80620,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615795,2013-02-14 14:00:47,set cell-type from tid,spermine levels in 3LL cells after the treatment of 50 microM of Compound,,,,,,847,BAO_0000219,,,,CLD0,0,0,CLD0,
430,15547,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,F,,,Homo sapiens,9606,,,3LLD122,,80621,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615590,2013-02-14 14:00:47,set cell-type from tid,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,,,,,,971,BAO_0000219,,,,CLD0,0,0,CLD0,
431,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,F,,,,,,,M5076,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL615591,2010-10-26 17:10:29,SQL-abbr-desc,In vivo antitumor activity of the compound against 3M531 is the sarcoma M5076; reproducible minimal activity,,,,,,516,BAO_0000218,,,,CLD0,0,0,CLD0,
432,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,F,,,,,,,M5076,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615592,2010-10-26 17:10:29,SQL-abbr-desc,In vivo antitumor activity of the compound against 3M531 is the sarcoma M5076; reproducible significant activity.,,,,,,516,BAO_0000218,,,,CLD0,0,0,CLD0,
433,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,F,,,,,,Capsule,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615593,2010-10-26 17:10:29,SQL-abbr-desc,In vivo antitumor activity of the compound against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,,,,,,,BAO_0000218,3893,,,CLD0,0,0,CLD0,
434,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,F,,,,,,Capsule,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615594,2010-10-26 17:10:29,SQL-abbr-desc,In vivo antitumor activity of the compound against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,,,,,,,BAO_0000218,3893,,,CLD0,0,0,CLD0,
435,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615595,2013-02-14 14:00:47,set cell-type from tid,Effective dose of the compound required against T.cruzi amastigotes in 3T3 Fibroblasts,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
436,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615596,2013-02-14 14:00:47,set cell-type from tid,Effective dose required against T.cruzi amastigotes in 3T3 Fibroblasts,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
437,12695,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,F,,,,,,,NIH3T3,,11169,H,8,Expert,30,ORIGINAL,1,,CHEMBL615597,2006-11-23 12:25:29,BautoJPO,Ability of the peptide to inhibit 6nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
438,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615598,2013-02-14 14:00:47,set cell-type from tid,Ability of the peptide to inhibit 6nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
439,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615599,2013-02-14 14:00:47,set cell-type from tid,Ability of the peptide to inhibit 6nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
440,17642,Effective dose against murine 3T3 fibroblasts cells,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,40,ORIGINAL,1,,CHEMBL615600,2013-02-14 14:00:47,set cell-type from tid,Effective dose of the compound against murine 3T3 fibroblasts cells,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
441,17642,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,4,ORIGINAL,1,,CHEMBL615601,2013-02-14 14:00:47,set cell-type from tid,Effective dose of the compound against murine 3T3 fibroblasts cells; 1-10uM,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
442,12340,Cytotoxic effect on 3T3 cells,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,1,ORIGINAL,1,,CHEMBL615602,2013-02-14 14:00:47,set cell-type from tid,Compound was evaluated for in vitro cytotoxicity of 3T3 cell lines,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
443,12340,Cytotoxic effect on 3T3 cells,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,13,ORIGINAL,1,,CHEMBL615603,2013-02-14 14:00:47,set cell-type from tid,Compound was evaluated for in vitro cytotoxicityof 3T3 cell lines,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
444,12716,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615604,2013-02-14 14:00:47,set cell-type from tid,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
445,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615605,2013-02-14 14:00:47,set cell-type from tid,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
446,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615606,2013-02-14 14:00:47,set cell-type from tid,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
447,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,13,ORIGINAL,1,,CHEMBL884526,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxic concentration of the compound against mouse fibroblasts (3T3) cell line using MTT coloration,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
448,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,7,ORIGINAL,1,,CHEMBL615607,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxic concentration of the compound against mouse fibroblasts (3T3) cell line using MTT coloration; n.d=no data,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
449,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615608,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxic concentration of the compound against mouse fibroblasts (3T3) cell line using MTT coloration; n.t=not tested,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
450,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,13,ORIGINAL,1,,CHEMBL615609,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibitory activity of the compound against mouse fibroblasts (3T3) cell line using CV coloration,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
451,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,7,ORIGINAL,1,,CHEMBL615682,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibitory activity of the compound against mouse fibroblasts (3T3) cell line using CV coloration; n.d=no data,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
452,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615683,2013-02-14 14:00:47,set cell-type from tid,In vitro inhibitory activity of the compound against mouse fibroblasts (3T3) cell line using CV coloration; n.t=not tested,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
453,17780,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,1,ORIGINAL,1,,CHEMBL615684,2013-02-14 14:00:47,set cell-type from tid,In vivo inhibitory concentration of the compound against H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,,,,,,723,BAO_0000218,,,,CLD0,0,0,CLD0,
454,12751,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,F,,,Mus musculus,10090,,,BALB/c3T3,,104860,D,7,Autocuration,9,ORIGINAL,1,,CHEMBL615685,2006-04-20 15:42:47,admin_actype,Inhibition of PDGF-dependent autophosphorylation in Balb/c3T3 fibroblast cells,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
455,12380,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,10,ORIGINAL,1,,CHEMBL615686,2013-02-14 14:00:47,set cell-type from tid,Inhibition of cell growth of Swiss 3T3 Mouse fibroblasts using cell culture and growth inhibition assay.,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
456,14892,Inhibitory activity against 3T3 cell line,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615687,2013-02-14 14:00:47,set cell-type from tid,Inhibitory activity against 3T3 cell line,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
457,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL884523,2013-02-14 14:00:47,set cell-type from tid,The ability of the peptide to inhibit the binding of 10pM [125I]Gastrin releasing peptide to S-3T3 cell membrane was measured,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
458,12695,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,F,,,,,,,S-3T3,,11169,H,8,Expert,29,ORIGINAL,1,,CHEMBL615688,2006-11-28 16:58:32,BautoJPO,The ability of the peptide to inhibit the binding of 10pM [125I]Gastrin releasing peptide to S-3T3 cell membrane was measured,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
459,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615689,2013-02-14 14:00:47,set cell-type from tid,The ability of the peptide to inhibit the binding of 10pM [125I]Gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
460,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615690,2013-02-14 14:00:47,set cell-type from tid,The ability of the peptide to inhibit the binding of 50pM [125I]Gastrin releasing peptide to intact S-3T3 cells was measured,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
461,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,F,,,,,,,S-3T3,,11169,H,8,Expert,18,ORIGINAL,1,,CHEMBL615691,2006-11-23 12:25:28,BautoJPO,The ability of the peptide to inhibit the binding of 50pM [125I]Gastrin releasing peptide to intact S-3T3 cells was measured,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
462,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,F,,,,,,,S-3T3,,11169,H,8,Expert,12,ORIGINAL,1,,CHEMBL615692,2006-11-28 16:58:32,BautoJPO,The ability of the peptide to inhibit the binding of 50pM [125I]Gastrin releasing peptide to intact S-3T3 cells was measured; nt=Not tested,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
463,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615693,2013-02-14 14:00:47,set cell-type from tid,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
464,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,17,ORIGINAL,1,,CHEMBL615324,2013-02-14 14:00:47,set cell-type from tid,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; n.d=no data,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
465,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,F,,,Homo sapiens,9606,,,NIH3T3,,9,D,9,Expert,11,ORIGINAL,1,,CHEMBL615325,2006-04-20 15:42:47,admin_actype,Inhibition of 3T3 proliferation by ligand induced BrdU incorporation in 3T3 cells overexpressing human EGF-R Kinase,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
466,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),F,,,Homo sapiens,9606,,,NIH3T3,,9,D,9,Expert,3,ORIGINAL,1,,CHEMBL615490,2006-04-20 15:42:47,admin_actype,Inhibition of 3T3 proliferation by ligand induced BrdU incorporation in 3T3 cells overexpressing human EGF-R Kinase ; NT=Not tested,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
467,4959,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,F,,,Homo sapiens,9606,,,NIH3T3,,188,D,9,Expert,11,ORIGINAL,1,,CHEMBL615491,2006-04-20 15:42:47,admin_actype,Inhibitory activity towards 3T3 proliferation by ligand induced BrdU incorporation in 3T3 cells overexpressing human Her-2 (p185erbB) tyrosine kinase,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
468,4959,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),F,,,Homo sapiens,9606,,,NIH3T3,,188,D,9,Expert,3,ORIGINAL,1,,CHEMBL615492,2006-04-20 15:42:47,admin_actype,Inhibitory activity towards 3T3 proliferation by ligand induced BrdU incorporation in 3T3 cells overexpressing human Her-2 (p185erbB) tyrosine kinase; Not tested,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
469,12082,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615493,2013-02-14 14:00:47,set cell-type from tid,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
470,12082,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615494,2013-02-14 14:00:47,set cell-type from tid,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
471,12082,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615495,2013-02-14 14:00:47,set cell-type from tid,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
472,12082,Inhibitory concentration was calculated on 3T3 cells by using growth assay,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615496,2013-02-14 14:00:47,set cell-type from tid,Inhibitory concentration was calculated on 3T3 cells by using growth assay,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
473,2643,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615497,2013-02-14 14:00:47,set cell-type from tid,In vitro cytotoxicity of the compound was evaluated in mouse embryo Balb/c 3T3 cells,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
474,11926,Inhibition of Swiss 3T3 mouse fibroblast proliferation,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,12,ORIGINAL,1,,CHEMBL615498,2013-02-14 14:00:47,set cell-type from tid,Inhibitory activity against the proliferation of Swiss 3T3 mouse fibroblasts,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
475,15204,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,A,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,7,ORIGINAL,1,,CHEMBL615499,2013-02-14 14:00:47,set cell-type from tid,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
476,15992,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,18,ORIGINAL,1,,CHEMBL835522,2013-02-14 14:00:47,set cell-type from tid,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
477,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615500,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity on 3T3 fibroblasts(3T3F) murine cell line (O.D=0.131+/-0.014); Not tested,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
478,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615501,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity against 3T3 fibroblasts(3T3F) murine cell line (O.D=0.131+/-0.014),,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
479,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615502,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity on 3T3 fibroblasts(3T3F) murine cell line (O.D=0.131+/-0.014),,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
480,16279,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615503,2013-02-14 14:00:47,set cell-type from tid,cytotoxicity on 3T3 fibroblasts(3T3F) murine cell line (O.D=0.131+/-0.014),,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
481,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615504,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity on 3T3 fibroblasts(3T3F) murine cell line (O.D=0.131+/-0.014),,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
482,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615505,2013-02-14 14:00:47,set cell-type from tid,Cytotoxicity against 3T3 fibroblasts(3T3F) murine cell line (O.D=0.131+/-0.014),,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
483,12831,Inhibition of swiss 3T3 mouse fibroblast proliferation,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Expert,5,ORIGINAL,1,,CHEMBL615506,2013-02-14 14:00:47,set cell-type from tid,Ability to inhibit 50% proliferation of swiss 3T3 mouse fibroblasts was determined,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
484,13497,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,F,,,Mus musculus,10090,,,NIH3T3,,80951,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615507,2013-02-14 14:00:47,set cell-type from tid,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,,,,,,723,BAO_0000219,,,,CLD0,0,0,CLD0,
485,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615508,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
486,13618,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615509,2013-02-14 14:00:47,set cell-type from tid,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48h incubation,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
487,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615510,2013-02-14 14:00:47,set cell-type from tid,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
488,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,3,ORIGINAL,1,,CHEMBL615511,2013-02-14 14:00:47,set cell-type from tid,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
489,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615512,2013-02-14 14:00:47,set cell-type from tid,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
490,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615513,2013-12-05 16:38:23,george_spelling,"Compound was evaluated in vitro for its ability to stimulate glucose transport in 3T3-L1 adipocytes ,given at 100mg/kg in mouse,after 24hours",,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
491,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615514,2013-12-05 16:38:23,george_spelling,"Compound was evaluated in vitro for its ability to stimulate glucose transport in 3T3-L1 adipocytes ,given at 100mg/kg in mouse,after 3hours",,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
492,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615515,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
493,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615516,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
494,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,5,ORIGINAL,1,,CHEMBL615517,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
495,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615518,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
496,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615519,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3micro M,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
497,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615520,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
498,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615521,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
499,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615522,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
500,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615523,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
501,13715,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,15,ORIGINAL,1,,CHEMBL615524,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
502,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,37,ORIGINAL,1,,CHEMBL615525,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
503,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,9,ORIGINAL,1,,CHEMBL615526,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
504,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615527,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
505,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615528,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
506,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,41,ORIGINAL,1,,CHEMBL615529,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
507,13715,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,19,ORIGINAL,1,,CHEMBL615530,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
508,13715,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,22,ORIGINAL,1,,CHEMBL615531,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
509,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615532,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
510,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615533,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
511,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615534,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
512,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,6,ORIGINAL,1,,CHEMBL615535,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
513,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615536,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
514,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615537,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
515,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615538,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
516,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL836166,2013-02-14 14:00:47,set cell-type from tid,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60microM dose.,,,,,,620,BAO_0000218,,,,CLD0,0,0,CLD0,
517,6411,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,F,,,,,,,3T3-L1,,11214,H,8,Expert,72,ORIGINAL,1,,CHEMBL615539,2006-04-20 15:42:47,admin_actype,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
518,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,2,ORIGINAL,1,,CHEMBL615540,2013-02-14 14:00:47,set cell-type from tid,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
519,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,F,,,,,,,3T3-L1,,11214,H,8,Expert,18,ORIGINAL,1,,CHEMBL615541,2006-04-20 15:42:47,admin_actype,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
520,3966,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,17,ORIGINAL,1,,CHEMBL615542,2013-12-04 12:39:36,george_spelling,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumlation from insulin regulated differentiation of 3T3-L1 cells at 1 microM expressed as percent activity of pioglitazone,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
521,3966,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Intermediate,7,ORIGINAL,1,,CHEMBL615543,2013-12-04 12:39:37,george_spelling,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumlation from insulin regulated differentiation of 3T3-L1 cells at 10 microM expressed as percent activity of pioglitazone,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
522,15556,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,25,ORIGINAL,1,,CHEMBL615544,2013-02-14 14:00:47,set cell-type from tid,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
523,5845,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,8,ORIGINAL,1,,CHEMBL615545,2013-02-14 14:00:47,set cell-type from tid,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
524,14422,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,40,ORIGINAL,1,,CHEMBL615546,2013-02-14 14:00:47,set cell-type from tid,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
525,5845,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,15,ORIGINAL,1,,CHEMBL615547,2013-02-14 14:00:47,set cell-type from tid,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 microM concentration in 3T3-L1 cells,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
526,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,29,ORIGINAL,1,,CHEMBL615548,2013-02-14 14:00:47,set cell-type from tid,In vitro glucose transport activity of the compound in 3T3-LI adipocytes at 10 microM concentration,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
527,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,29,ORIGINAL,1,,CHEMBL615549,2013-02-14 14:00:47,set cell-type from tid,In vitro glucose transport activity of the compound in 3T3-LI adipocytes at 3 microM concentration,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
528,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,F,,,Mus musculus,10090,,,3T3-L1,,80006,N,1,Expert,29,ORIGINAL,1,,CHEMBL615550,2013-02-14 14:00:47,set cell-type from tid,In vitro glucose transport activity of the compound in 3T3-LI adipocytes at 30 microM concentration,,,,,,620,BAO_0000219,,,,CLD0,0,0,CLD0,
529,6349,Inhibitory activity against rat fibroblast (3Y1) cell line,F,,,Rattus norvegicus,10116,,,3Y1 cell line,,80622,N,1,Intermediate,4,ORIGINAL,1,,CHEMBL615551,2013-02-14 14:00:47,set cell-type from tid,Inhibitory activity of the compound against rat fibroblast (3Y1) cell line,,,,,,1118,BAO_0000219,,,,CLD0,0,0,CLD0,
530,15899,Mean concentration causing inhibition of cell growth in 3Y1 cells.,F,,,Rattus norvegicus,10116,,,3Y1 cell line,,80622,N,1,Expert,20,ORIGINAL,1,,CHEMBL615552,2013-02-14 14:00:47,set cell-type from tid,Mean averaged concentration that causes 50% growth inhibition,,,,,,1118,BAO_0000219,,,,CLD0,0,0,CLD0,
531,15899,Cytotoxicity in 3Y1 cells.,F,,,Rattus norvegicus,10116,,,3Y1 cell line,,80622,N,1,Expert,20,ORIGINAL,1,,CHEMBL615553,2013-02-14 14:00:47,set cell-type from tid,"Concentration for killing 50% of cells, which signifies cytotoxic effect",,,,,,1118,BAO_0000219,,,,CLD0,0,0,CLD0,
532,15899,Cytostatic effect in 3Y1 cells.,F,,,Rattus norvegicus,10116,,,3Y1 cell line,,80622,N,1,Expert,19,ORIGINAL,1,,CHEMBL615554,2013-02-14 14:00:47,set cell-type from tid,"Mean averaged concentration for total growth inhibition , which signifies cytostatic effect.",,,,,,1118,BAO_0000219,,,,CLD0,0,0,CLD0,
533,15899,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",F,,,Rattus norvegicus,10116,,,3Y1 cell line,,80622,N,1,Intermediate,1,ORIGINAL,1,,CHEMBL615555,2013-02-14 14:00:47,set cell-type from tid,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",,,,,,1118,BAO_0000219,,,,CLD0,0,0,CLD0,
534,17038,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,F,,,Rattus norvegicus,10116,,,3Y1 cell line,,80622,N,1,Expert,24,ORIGINAL,1,,CHEMBL615556,2013-02-14 14:00:47,set cell-type from tid,Concentration of the compound required to inhibit the growth of normal rat fibroblast cells (3Y1-Bcells) after 72 h exposure,,,,,,1118,BAO_0000219,,,,CLD0,0,0,CLD0,
535,12421,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,B,,,,,,,,,22226,U,0,Autocuration,71,ORIGINAL,1,,CHEMBL615557,2006-04-20 15:43:45,admin_actype,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta5-steriod dehydrogenase/3-keto-delta5-steriod isomerase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
536,12947,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,B,,,,,,,,,22226,U,0,Autocuration,31,ORIGINAL,1,,CHEMBL615558,2006-11-28 16:58:32,BautoJPO,Inhibition of recombinant human adrenal 3beta-hydroxy-delta-5-steroid dehydrogenase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
537,12947,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,B,,,,,,,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL872066,2013-12-05 18:44:55,george_spelling,Inhibition of recombinant rat  adrenal 3beta-hydroxy-delta-5-steroid dehydrogenase,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
538,4896,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,B,,,Sus scrofa,9823,,,,,11607,D,9,Expert,11,ORIGINAL,1,,CHEMBL615559,2006-04-20 15:42:47,admin_actype,Compound was tested in vitro for its inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
539,6148,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,B,,,,,,,,,11607,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615560,2006-04-20 15:42:47,admin_actype,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
540,16432,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,B,,,,,,,,,11607,H,8,Autocuration,10,ORIGINAL,1,,CHEMBL615561,2006-04-20 15:42:47,admin_actype,Inhibiton of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
541,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,B,,,,,,,,,11607,H,8,Expert,27,ORIGINAL,1,,CHEMBL857062,2006-04-20 15:44:07,admin_actype,Concentration of the compound required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
542,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),B,,,,,,,,,11607,H,8,Expert,27,ORIGINAL,1,,CHEMBL615562,2006-04-20 15:44:07,admin_actype,Concentration of the compound required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
543,3723,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,B,,,,,,,,,11607,H,8,Autocuration,9,ORIGINAL,1,,CHEMBL615563,2010-10-26 17:10:29,SQL-abbr-desc,In vitro inhibitory activity of the compound against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
544,3518,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),B,,,,,,,,,11607,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615564,2004-10-31 12:48:03,admin,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
545,4164,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,B,,,,,,,,,11607,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615565,2010-09-23 11:52:22,SQL-abbr-desc,Compound was evaluated in vitro for the inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
546,3518,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,B,,,,,,,,,11607,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615566,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
547,4164,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,B,,,Sus scrofa,9823,,,,,11607,D,9,Expert,13,ORIGINAL,1,,CHEMBL615567,2006-04-20 15:42:47,admin_actype,The compound was evaluated in vitro for the inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
548,3518,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,B,,,,,,,,,11607,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615568,2010-10-26 17:10:29,SQL-abbr-desc,The inhibitory activity of the compound on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
549,3518,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),B,,,,,,,,,11607,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615569,2006-04-20 15:43:45,admin_actype,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
550,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,B,,,,,,,,,11607,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615570,2010-10-26 17:10:29,SQL-abbr-desc,Concentration of the compound required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
551,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),B,,,,,,,,,11607,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615571,2010-10-26 17:10:29,SQL-abbr-desc,Concentration of the compound required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
552,6455,Binding affinity against melatonin (MT1) receptor (pC1),B,,,,,,,,,104733,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615572,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound against melatonin (MT1) receptor (pC1),,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
553,2222,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615573,2006-04-20 15:42:47,admin_actype,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
554,13020,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,B,,,,,,,,,22226,U,0,Autocuration,3,ORIGINAL,1,,CHEMBL615574,2006-11-28 17:04:09,BautoJPO,Inhibition of [3H] 5-HT binding to 5-hydroxytryptamine 1 receptor at a concentration of 10e-5M of the compound,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
555,13021,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,B,,,,,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615575,2006-11-28 16:58:32,BautoJPO,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor present in the central nervous system.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
556,14532,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,B,,,,,,,,,10619,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615576,2006-11-28 17:04:09,BautoJPO,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10E-5M concentration,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
557,14118,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,B,,,,,,,,,10619,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615577,2006-11-28 17:04:09,BautoJPO,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]serotonin as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
558,11884,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615578,2006-04-20 15:43:45,admin_actype,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]-8-OH-DPAT,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
559,13969,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,35,ORIGINAL,1,,CHEMBL615579,2006-04-20 15:44:07,admin_actype,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
560,13392,Binding affinity for 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,47,ORIGINAL,1,,CHEMBL615580,2006-04-20 15:44:07,admin_actype,Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
561,14430,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,B,,,,,,,,,51,H,8,Expert,21,ORIGINAL,1,,CHEMBL615581,2006-04-20 15:42:47,admin_actype,Compound was evaluated for Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]-OH-DPAT,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
562,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615582,2006-04-20 15:42:47,admin_actype,Compound was evaluated for the binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
563,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615583,2006-04-20 15:42:47,admin_actype,Compound was evaluated for the binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
564,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615584,2006-11-28 16:58:32,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-5-HT(2nM) binding to 5-HT1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
565,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL833691,2006-11-23 12:25:19,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-5-HT(2nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
566,9995,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615585,2006-11-28 16:58:32,BautoJPO,Compound was tested in vitro for the inhibition of azido-[125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
567,9995,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615586,2006-11-23 12:25:28,BautoJPO,Compound was tetsed in vitro for the inhibition of [125I]-IPAPP (0.25nM) binding to 5-HT1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
568,9995,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL884524,2006-11-23 12:25:26,BautoJPO,Compound was tetsed in vitro for the inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
569,12249,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615587,2006-04-20 15:42:47,admin_actype,Inhibitory concentration against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
570,11799,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",B,,,,,,Hippocampus,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615588,2006-04-20 15:43:24,admin_actype,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]-8-OH-DPAT as radioligand",,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
571,14331,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,B,,,Rattus norvegicus,10116,,,,Membrane,10576,D,9,Expert,11,ORIGINAL,1,,CHEMBL615589,2006-04-20 15:43:45,admin_actype,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT and bovine hippocampal membranes + frontal cortex,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
572,11884,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,B,,,Bos taurus,9913,,Hippocampus,,,51,H,8,Expert,13,ORIGINAL,1,,CHEMBL615442,2006-04-20 15:43:45,admin_actype,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]-8-OH-DPAT,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
573,14331,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615443,2006-04-20 15:43:45,admin_actype,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
574,11701,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615444,2006-11-28 16:58:32,BautoJPO,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
575,11701,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,B,,,,,,Hippocampus,,,51,H,8,Expert,32,ORIGINAL,1,,CHEMBL615445,2006-11-28 16:58:32,BautoJPO,Compound was evaluated for its ability to displace [3H]DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
576,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615446,2006-04-20 15:43:45,admin_actype,Compound was evaluated for the binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
577,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615447,2006-04-20 15:43:45,admin_actype,Compound was evaluated for the binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
578,12248,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,26,ORIGINAL,1,,CHEMBL615448,2006-04-20 15:43:45,admin_actype,Compound was evaluated for the binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
579,12249,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,25,ORIGINAL,1,,CHEMBL615449,2006-04-20 15:43:45,admin_actype,Compound was evaluated for the binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
580,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615450,2006-04-20 15:43:45,admin_actype,Compound was evaluated for the binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
581,11799,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",B,,,,,,Hippocampus,,,51,H,8,Expert,58,ORIGINAL,1,,CHEMBL615451,2006-04-20 15:43:45,admin_actype,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]-8-OH-DPAT as radioligand",,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
582,634,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,B,,,,,,,,,51,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615452,2006-11-23 12:25:28,BautoJPO,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
583,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615453,2006-11-28 16:58:32,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-5-HT(2nM) binding to 5-HT1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
584,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615454,2006-11-28 16:58:32,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-5-HT(2nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
585,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615455,2006-11-23 12:25:28,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-DPAT(1nM) binding to 5-HT1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
586,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615456,2006-11-28 16:58:32,BautoJPO,Compound was tested in vitro for the inhibition of [3H]-DPAT(1nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
587,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615457,2006-11-23 12:25:28,BautoJPO,Compound was tetsed in vitro for the inhibition of [3H]-DPAT(1nM) binding to 5-HT1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
588,12210,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,B,,,,,,Hippocampus,,,51,H,8,Expert,37,ORIGINAL,1,,CHEMBL615458,2006-04-20 15:43:45,admin_actype,In vivo binding affinity towards [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,,,,,,BAO_0000218,10000000,,,CLD0,0,0,CLD0,
589,13311,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,54,ORIGINAL,1,,CHEMBL615459,2006-04-20 15:43:45,admin_actype,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
590,2331,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",B,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,10,ORIGINAL,1,,CHEMBL615460,2006-04-20 15:43:45,admin_actype,"Tested in vitro for the inhibition of [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
591,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,F,,,Cavia porcellus,10141,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615461,2006-04-20 15:42:24,admin_actype,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
592,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,F,,,Cavia porcellus,10141,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615462,2006-04-20 15:42:24,admin_actype,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
593,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,F,,,Cavia porcellus,10141,,Hippocampus,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615463,2010-10-26 17:10:29,SQL-abbr-desc,Effect of the compound on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
594,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,B,,,Cavia porcellus,10141,,Ileum,,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615464,2006-11-28 16:58:32,BautoJPO,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5HT1A receptor.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
595,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141,,Ileum,,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615465,2011-01-19 17:05:08,LJB Desc Spelling,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5HT1A receptor.Inactive at dose level of 1.0 microM.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
596,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,B,,,Cavia porcellus,10141,,Ileum,,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615466,2006-11-28 16:58:32,BautoJPO,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5HT1A receptor.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
597,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141,,Ileum,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615467,2011-01-19 17:05:03,LJB Desc Spelling,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5HT1A receptor. Inactive at dose level of 1.0 microM.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
598,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141,,Ileum,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615468,2011-01-19 17:05:03,LJB Desc Spelling,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5HT1A receptor.Inactive at dose level of 1.0 microM.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
599,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141,,Ileum,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615469,2011-01-19 17:05:03,LJB Desc Spelling,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5HT1A receptor; Inactive at dose level of 1.0 microM.,,,,,,,BAO_0000221,2116,,,CLD0,0,0,CLD0,
600,11574,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141,,,,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615470,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
601,13114,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615471,2006-04-20 15:42:47,admin_actype,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
602,13181,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615472,2006-04-20 15:44:08,admin_actype,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
603,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,B,,,Cavia porcellus,10141,,Hippocampus,,,106,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL883242,2006-04-20 15:42:24,admin_actype,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
604,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,F,,,Cavia porcellus,10141,,Hippocampus,,,106,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615473,2006-04-20 15:42:24,admin_actype,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
605,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),B,,,Cricetulus griseus,10029,,,CHO,,11863,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615474,2006-04-20 15:43:45,admin_actype,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO-cells (sc),,,,,,449,BAO_0000218,,,,CLD0,0,0,CLD0,
606,17785,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615475,2010-10-26 17:10:29,SQL-abbr-desc,Fraction of the compound involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
607,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,F,,,,,,,HeLa,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615476,2006-04-20 15:42:24,admin_actype,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
608,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,F,,,,,,,HeLa,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615477,2006-04-20 15:42:24,admin_actype,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
609,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615478,2011-01-19 17:04:42,LJB Desc Spelling,EC50 for inhibition of 50 microM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
610,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615160,2013-12-05 18:44:55,george_spelling,Effective concentration against binding of radioligand [35]GTPgammaS in CHO cells expressing human 5-hydroxytryptamine 1A  receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
611,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Expert,19,ORIGINAL,1,,CHEMBL615161,2006-04-20 15:42:24,admin_actype,Effective concentration against binding of radioligand [35]GTPgammaS in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
612,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615162,2006-04-20 15:42:24,admin_actype,Effective concentration against binding of radioligand [35]GTPgammaS in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
613,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615163,2006-04-20 15:42:24,admin_actype,Effective concentration against binding of radioligand [35]GTPgammaS in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
614,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Expert,8,ORIGINAL,1,,CHEMBL615164,2006-04-20 15:42:24,admin_actype,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
615,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Expert,9,ORIGINAL,1,,CHEMBL615165,2006-04-20 15:42:24,admin_actype,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=Not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
616,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,B,,,,,,,CHO,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615166,2006-04-20 15:42:24,admin_actype,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
617,14256,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,F,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615167,2006-04-20 15:42:24,admin_actype,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
618,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,B,,,Homo sapiens,9606,,,HeLa,,51,D,9,Expert,10,ORIGINAL,1,,CHEMBL615168,2006-11-23 12:25:28,BautoJPO,Stimulation of [35S] GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
619,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,B,,,Homo sapiens,9606,,,HeLa,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL615169,2006-11-28 16:58:32,BautoJPO,Stimulation of [35S] GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
620,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,6,ORIGINAL,1,,CHEMBL615170,2006-04-20 15:42:24,admin_actype,Tested for functional response of the compound on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
621,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,B,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,5,ORIGINAL,1,,CHEMBL615171,2006-04-20 15:42:24,admin_actype,Tested for functional response of the compound on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
622,15180,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615694,2010-10-26 17:10:29,SQL-abbr-desc,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values of the compound against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
623,15180,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615695,2010-10-26 17:10:29,SQL-abbr-desc,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values of the compound against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
624,16026,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",F,,,,,,,HeLa,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615696,2006-12-04 17:22:51,BautoJPO,Percent of maximum effect on binding of [35S]GTP-gamma-S to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
625,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615697,2004-10-31 12:48:03,admin,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
626,2759,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),F,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,10,ORIGINAL,1,,CHEMBL859410,2006-04-24 00:00:00,ylight,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
627,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615841,2011-06-09 17:19:30,F_type_fix,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
628,2759,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),F,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,9,ORIGINAL,1,,CHEMBL615842,2006-04-27 00:00:00,ylight,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
629,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL835003,2004-10-31 12:48:03,admin,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
630,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615843,2011-06-09 17:19:30,F_type_fix,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
631,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),F,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,9,ORIGINAL,1,,CHEMBL615979,2006-04-27 00:00:00,ylight,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
632,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615980,2011-06-09 17:19:30,F_type_fix,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
633,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),F,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,9,ORIGINAL,1,,CHEMBL615981,2006-04-27 00:00:00,ylight,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
634,3445,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL615982,2006-03-27 00:00:00,davidm,Percent effficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
635,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,8,ORIGINAL,1,,CHEMBL615983,2011-06-09 17:19:30,F_type_fix,Agonist activity of the compound at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]-GTPgS,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
636,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL615984,2011-06-09 17:19:30,F_type_fix,Agonist activity of the compound at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]-GTPgS; No data,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
637,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL615985,2011-06-09 17:19:30,F_type_fix,Agonist activity of the compound at the5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]-GTPgS,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
638,17624,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615986,2011-06-09 17:19:30,F_type_fix,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
639,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615987,2013-12-05 18:44:55,george_spelling,Agonistic effect against 5-hydroxytryptamine 1A  receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
640,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615988,2013-12-05 18:44:55,george_spelling,Agonistic effect against 5-hydroxytryptamine 1A  receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
641,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Expert,16,ORIGINAL,1,,CHEMBL615989,2011-06-09 17:19:30,F_type_fix,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
642,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615990,2011-06-09 17:19:30,F_type_fix,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
643,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615991,2011-06-09 17:19:30,F_type_fix,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
644,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615992,2011-06-09 17:19:30,F_type_fix,Agonistic effect of the compound against 5-HT 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
645,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615993,2011-06-09 17:19:30,F_type_fix,Agonistic effect of the compound against 5-HT 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
646,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Expert,22,ORIGINAL,1,,CHEMBL615994,2013-12-05 18:44:55,george_spelling,Agonistic effect of the compound against 5-hydroxytryptamine 1A  receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
647,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615995,2013-12-05 18:44:55,george_spelling,Agonistic effect of the compound against 5-hydroxytryptamine 1A  receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
648,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615996,2011-06-09 17:19:30,F_type_fix,Agonistic effect of the compound against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
649,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615997,2011-06-09 17:19:30,F_type_fix,Agonistic effect of the compound against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
650,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615998,2006-12-04 17:22:51,BautoJPO,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTPgS stimulated cAMP assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
651,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615999,2006-12-04 17:22:55,BautoJPO,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTPgammaS stimulated cAMP assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
652,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,F,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616000,2013-12-04 13:31:57,george_spelling,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskloin stimulated cAMP assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
653,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL616001,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gammaS,,,,,,722,BAO_0000219,,,,CLD0,0,0,CLD0,
654,6876,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,14,ORIGINAL,1,,CHEMBL616002,2006-12-04 17:22:51,BautoJPO,Compound was evaluated for stimulation at 1uM concentration expressed as percent of the maximal [35S]GTPgammaS binding induced by 5-hydroxytryptamine,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
655,6876,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",F,,,,,,,,,51,H,8,Expert,1,ORIGINAL,1,,CHEMBL616003,2006-12-04 17:22:55,BautoJPO,Compound was evaluated for stimulation at 1uM concentration expressed as percent of the maximal [35S]GTPgammaS binding induced by 5-hydroxytryptamine ; nd - not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
656,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,8,ORIGINAL,1,,CHEMBL616004,2011-06-09 17:19:30,F_type_fix,In vitro agonist activity of the compound at the 5-hydroxytryptamine 1A receptor was determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
657,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,2,ORIGINAL,1,,CHEMBL616005,2011-06-09 17:19:30,F_type_fix,In vitro agonist activity of the compound at the 5-hydroxytryptamine 1A receptor was determined; No data,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
658,5548,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616006,2010-10-26 17:10:29,SQL-abbr-desc,Maximal response of the compound as a result of 5-HT1A receptor-mediated stimulation of [35S]GTPgammaS binding; Not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
659,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",F,,,,,,,,,51,H,8,Expert,15,ORIGINAL,1,,CHEMBL616007,2006-12-04 17:22:51,BautoJPO,Maximal response of the compound as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTPgammaS binding,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
660,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL616008,2010-10-26 17:10:29,SQL-abbr-desc,Maximal response of the compound as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTPgammaS binding; Not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
661,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616009,2010-10-26 17:10:29,SQL-abbr-desc,Maximal response of the compound as a result of 5-hydroxytryptamine 1A receptormediated stimulation of [35S]GTPgammaS binding; Not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
662,5929,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",F,,,,,,,,,51,H,8,Expert,21,ORIGINAL,1,,CHEMBL616010,2006-12-04 17:22:55,BautoJPO,Maximal response of the compound towards 5-hydroxytryptamine 1A receptor in human using [35S]GTPgammaS as radioligand,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
663,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,2,ORIGINAL,1,,CHEMBL616011,2006-12-04 17:22:51,BautoJPO,Maximal response of the compound towards 5-hydroxytryptamine 1A receptor in human using [35S]GTPgammaS as radioligand; ND means not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
664,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,11,ORIGINAL,1,,CHEMBL615740,2006-12-04 17:22:51,BautoJPO,Maximal response of the compound towards 5-hydroxytryptamine 1A receptor in human using [35S]GTPgammaS as radioligand; ND=Not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
665,16245,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615741,2006-12-04 17:22:51,BautoJPO,Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTPgammaS binding assay on 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
666,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",F,,,,,,,,,51,H,8,Expert,19,ORIGINAL,1,,CHEMBL615742,2006-12-04 17:22:51,BautoJPO,5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTPgS binding that was induced by 5-HT,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
667,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",F,,,,,,,,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615743,2013-12-19 14:16:36,george_spelling,5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTPgS binding that was induced by 5-HT; Emin (%) : not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
668,14509,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615744,2011-06-09 17:19:30,F_type_fix,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
669,14509,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,F,,,,,,,CHO,,51,H,8,Expert,34,ORIGINAL,1,,CHEMBL615745,2004-11-18 00:00:00,richardb,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
670,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615746,2013-12-05 18:44:55,george_spelling,Affinity of compound towards 5-hydroxytryptamine 1A receptor  was evaluated using radioligand binding technique,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
671,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615747,2006-04-20 15:42:47,admin_actype,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
672,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615748,2006-12-04 17:22:55,BautoJPO,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTPgammaS stimulated cAMP assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
673,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",F,,,,,,,,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615749,2006-12-04 17:22:51,BautoJPO,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTPgammaS stimulated cAMP assay; NA indicates not available,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
674,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,F,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615750,2013-12-04 13:31:57,george_spelling,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskloin stimulated cAMP assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
675,6563,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,8,ORIGINAL,1,,CHEMBL616259,2006-04-20 15:42:47,admin_actype,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskloin stimulated cAMP assay; NA indicates not available,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
676,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616260,2006-12-04 17:22:51,BautoJPO,Agonsitic activity of compound towards5-hydroxytryptamine 1A receptor was evaluated by [35S]GTPgammaS stimulated cAMP assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
677,5272,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,7,ORIGINAL,1,,CHEMBL616261,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the 5-hydroxytryptamine 1A receptor was determined in vitro,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
678,5272,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,5,ORIGINAL,1,,CHEMBL616262,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]-GTPgS,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
679,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,2,ORIGINAL,1,,CHEMBL616263,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]-GTPgS; No data,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
680,5272,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL616264,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
681,5272,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL616265,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the5-hydroxytryptamine 1A receptor was determined in vitro,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
682,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,2,ORIGINAL,1,,CHEMBL616266,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]-GTPgS,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
683,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL616267,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]-GTPgS; No data,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
684,5272,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL616268,2011-06-09 17:19:30,F_type_fix,Antagonism of the compound at the5-hydroxytryptamine 1A receptor was determined in vitro; No data,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
685,16146,Inhibition of human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,7,ORIGINAL,1,,CHEMBL616269,2006-04-20 15:42:47,admin_actype,Binding affinity against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
686,17624,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL884528,2013-12-05 18:44:55,george_spelling,Binding affinity of the compound against 5-hydroxytryptamine 1A  receptor using cAMP as radioligand in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
687,13706,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,B,,,,,,,HEK293,,105,H,8,Expert,5,ORIGINAL,1,,CHEMBL616270,2013-03-07 15:11:27,target_check,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,,,,,,722,BAO_0000219,,,,CLD0,0,0,CLD0,
688,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616271,2006-04-20 15:42:47,admin_actype,Compound was tested for the displacement of [3H]-5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
689,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616272,2006-04-20 15:42:47,admin_actype,Effective concentration against binding of radioligand [35]GTPgammaS in CHO cells expressing 5-hydroxytryptamine 1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
690,6861,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,B,,,,,,,,,51,H,8,Expert,22,ORIGINAL,1,,CHEMBL616273,2010-10-26 17:10:29,SQL-abbr-desc,In vitro binding affinity of the compound against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in human CYP3A4 assay,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
691,17200,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,10,ORIGINAL,1,,CHEMBL616274,2006-11-28 16:58:32,BautoJPO,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
692,17624,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616275,2006-04-20 15:42:47,admin_actype,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
693,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616276,2013-12-05 18:44:55,george_spelling,Inhibition concentration against 5-hydroxytryptamine 1A  receptor using cAMP as radioligand in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
694,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,3,ORIGINAL,1,,CHEMBL616277,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
695,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL616278,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
696,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL616279,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
697,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL616280,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
698,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL616281,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
699,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL616282,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration;Inactive,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
700,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL616283,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
701,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL616284,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
702,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,3,ORIGINAL,1,,CHEMBL616285,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
703,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,5,ORIGINAL,1,,CHEMBL616286,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
704,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL616287,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
705,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,3,ORIGINAL,1,,CHEMBL616288,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
706,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL616289,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
707,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615610,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
708,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL615611,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
709,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL615612,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
710,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615613,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
711,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615614,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
712,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,F,In vivo,,Rattus norvegicus,10116,,Brain,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615615,2006-04-20 15:42:35,admin_actype,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,,,,,,BAO_0000218,955,,,CLD0,0,0,CLD0,
713,11440,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,B,,,,,,,,,105093,H,4,Autocuration,2,ORIGINAL,1,,CHEMBL615616,2010-10-26 17:10:29,SQL-abbr-desc,Affinity of the compound in displacing [125I]-(R)-DOI from rat cortical homogenate 5-HT2 receptor.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
714,6238,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,B,,,,,,Hypothalamus,,,11923,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615617,2013-12-04 13:41:58,george_spelling,Binding affinity of the compound towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]-5-CT as radioligand,,,,,,,BAO_0000249,1898,,,CLD0,0,0,CLD0,
715,10046,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,B,,,,,,,,,10577,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615618,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory activity of the compound against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
716,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,B,,,,,,,,,10577,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615619,2013-12-19 14:25:52,george_spelling,Inhibitory activity of the compound against 5-Hyrdroxytryptamine1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand ;nd is No Data.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
717,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,B,,,,,,,,,10577,H,8,Expert,16,ORIGINAL,1,,CHEMBL615620,2006-11-23 12:25:29,BautoJPO,Inhibitory activity of the compound against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
718,167,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,55,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615621,2010-10-26 17:10:29,SQL-abbr-desc,"Inhibitory activity of the compound against human whole blood, LTB4 5-lipoxygenase was evaluated",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
719,167,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,55,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615622,2010-10-26 17:10:29,SQL-abbr-desc,"Inhibitory activity of the compound against intact human PMNL, LTB4 5-lipoxygenase was evaluated",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
720,11520,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),F,,,,,,,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615623,2006-04-20 15:43:22,admin_actype,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
721,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615624,2013-12-04 13:56:19,george_spelling,Compound was evaluated for the inhibition of 5-LO(lipooxigenase).,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
722,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615625,2013-12-04 13:56:20,george_spelling,"Compound was evaluated for the inhibition of, 5-LO(lipooxigenase).",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
723,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL767045,2013-12-04 13:56:20,george_spelling,"Compound was evaluated for the inhibition of,5-LO(lipooxigenase).",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
724,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,F,,,Cavia porcellus,10141,,,,,55,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615626,2006-11-28 17:04:09,BautoJPO,Inhibition of 14C-arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
725,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,F,,,Cavia porcellus,10141,,,,,55,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615627,2013-12-19 14:17:24,george_spelling,Inhibition of 14C-arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested ; No activity,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
726,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,B,,,Cavia porcellus,10141,,,,,55,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615628,2006-04-20 15:42:47,admin_actype,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
727,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,B,,,Cavia porcellus,10141,,,,,55,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615629,2011-01-19 17:04:23,LJB Desc Spelling,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
728,12281,Inhibitory concentration against 5-lipoxygenase from human whole blood,B,,,Homo sapiens,9606,,Blood,,,55,D,9,Expert,11,ORIGINAL,1,,CHEMBL615630,2006-04-20 15:42:47,admin_actype,Inhibitory concentration of the compound against 5-lipoxygenase from human whole blood,,,,,,,BAO_0000221,178,,,CLD0,0,0,CLD0,
729,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],B,,,,,,,,,55,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615631,2006-04-20 15:42:47,admin_actype,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
730,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,F,,,,,,,,,17087,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615632,2006-04-20 15:42:35,admin_actype,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
731,12281,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,B,,,,,,,,,17087,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615633,2010-10-26 17:10:29,SQL-abbr-desc,Inhibitory concentration of the compound against 5-lipoxygenase from mouse macrophage,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
732,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,F,,,,,,,,,17087,H,8,Autocuration,11,ORIGINAL,1,,CHEMBL615634,2006-04-20 15:43:24,admin_actype,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
733,11089,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,B,,,Sus scrofa,9823,,,,,55,H,8,Expert,32,ORIGINAL,1,,CHEMBL615635,2006-04-20 15:42:47,admin_actype,The compound was tested for the inhibition of Arachidonate 5-Lipoxygenase purified from porcine leukocytes.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
734,11006,In vitro inhibition of rat 5-Lipoxygenase,B,,,,,,,,,12166,H,8,Expert,34,ORIGINAL,1,,CHEMBL615636,2006-04-20 15:42:47,admin_actype,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
735,11481,Inhibitory activity against 5-Lipoxygenase,B,,,Rattus norvegicus,10116,,,,,12166,D,9,Expert,4,ORIGINAL,1,,CHEMBL615637,2006-04-20 15:42:47,admin_actype,Compound was evaluated in vitro for its inhibitory activity against 5-Lipoxygenase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
736,10864,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,B,,,,,,,RBL-1,,12166,H,8,Expert,28,ORIGINAL,1,,CHEMBL615638,2006-04-20 15:42:47,admin_actype,Inhibitory activity against 5-LO in rat basophilic leukemia (RBL) cells using whole cell 5-LO (5-Lipoxygenase) assay.,,,,,,702,BAO_0000219,,,,CLD0,0,0,CLD0,
737,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615639,2006-04-20 15:42:47,admin_actype,Inhibitory activity against 5-lipoxygenase(5-LO) in intact rat barophilic leukemia cells (RBL-1),,,,,,702,BAO_0000219,,,,CLD0,0,0,CLD0,
738,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,B,,,,,,,RBL-1,,12166,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615640,2006-04-20 15:42:47,admin_actype,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,,,,,,702,BAO_0000219,,,,CLD0,0,0,CLD0,
739,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,B,,,,,,Blood,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615796,2006-04-20 15:42:47,admin_actype,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,,,,,,,BAO_0000221,178,,,CLD0,0,0,CLD0,
740,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615845,2006-04-20 15:42:47,admin_actype,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
741,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615846,2011-01-19 17:04:47,LJB Desc Spelling,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
742,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615847,2006-11-28 16:58:32,BautoJPO,Inhibitory activity against 5-lipoxygenase(5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10microM,,,,,,702,BAO_0000219,,,,CLD0,0,0,CLD0,
743,11311,The compound was tested for inhibition of isolated 5-Lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615848,2006-04-20 15:43:24,admin_actype,The compound was tested for inhibition of isolated 5-Lipoxygenase,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
744,11481,Ratio of IC50 against 5-LO and COX,B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,4,ORIGINAL,1,,CHEMBL615849,2006-03-10 00:00:00,ylight,Ratio of IC50 against 5-LO to that of CO enzyme.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
745,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615850,2011-01-19 17:04:47,LJB Desc Spelling,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
746,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,B,,,,,,,,,12166,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615851,2011-01-19 17:04:41,LJB Desc Spelling,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
747,11311,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615852,2006-11-28 16:58:32,BautoJPO,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10uM concentration,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
748,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,F,,,,,,,,,12166,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615853,2006-04-20 15:42:35,admin_actype,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
749,4288,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,B,,,,,,Prostate gland,,,120,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL884527,2006-04-20 15:42:47,admin_actype,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,,,,,,,BAO_0000221,2367,,,CLD0,0,0,CLD0,
750,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,B,,,Columba livia,8932,,,,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL872871,2006-04-20 15:43:24,admin_actype,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
751,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,B,,,Columba livia,8932,,,,,22226,U,0,Autocuration,2,ORIGINAL,1,,CHEMBL615854,2006-04-20 15:43:24,admin_actype,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
752,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,B,,,Columba livia,8932,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL767046,2006-04-20 15:43:24,admin_actype,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
753,11249,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,B,,,,,,,,,10732,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615855,2011-01-19 17:04:32,LJB Desc Spelling,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 microM,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
754,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,F,,,Rattus norvegicus,10116,,,,,12198,D,9,Expert,5,ORIGINAL,1,,CHEMBL615856,2006-04-20 15:42:47,admin_actype,Effect of compound on synaptosomal uptake inhibition of 5-hydroxytrypamine (5-HT); NT = Not Tested,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
755,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),F,,,Rattus norvegicus,10116,,,,,12198,D,9,Expert,13,ORIGINAL,1,,CHEMBL615857,2006-04-20 15:42:47,admin_actype,Effect of compound on synaptosomal uptake inhibition of 5-hydroxytrypamine (5-HT),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
756,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),F,,,Rattus norvegicus,10116,,,,,12198,D,9,Expert,11,ORIGINAL,1,,CHEMBL615858,2006-04-20 15:42:47,admin_actype,Effect of compound on synaptosomal uptake inhibition of 5-hydroxytrypamine (5-HT),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
757,12416,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,31,ORIGINAL,1,,CHEMBL615859,2006-04-20 15:42:47,admin_actype,Compound was evaluated in vitro for its affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
758,16293,Binding affinity towards human 5-hydroxytryptamine 1 receptor,B,,,,,,,,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615860,2006-04-20 15:43:45,admin_actype,Binding affinity towards human 5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
759,13047,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986,,Saphenous vein,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615861,2004-10-31 12:48:03,admin,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,,,,,,BAO_0000221,7318,,,CLD0,0,0,CLD0,
760,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986,,Saphenous vein,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615862,2004-10-31 12:48:03,admin,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,,,,,,BAO_0000221,7318,,,CLD0,0,0,CLD0,
761,13047,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986,,Saphenous vein,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615863,2004-10-31 12:48:03,admin,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,,,,,,,BAO_0000221,7318,,,CLD0,0,0,CLD0,
762,13047,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986,,Saphenous vein,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL615864,2004-10-31 12:48:03,admin,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,,,,,,BAO_0000221,7318,,,CLD0,0,0,CLD0,
763,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,7,ORIGINAL,1,,CHEMBL615865,2013-12-05 18:44:55,george_spelling,Ability to bind at 5-hydroxytryptamine 1 receptor  of rat hippocampus by displacing [3H]serotonin,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
764,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,7,ORIGINAL,1,,CHEMBL615866,2006-11-28 17:04:09,BautoJPO,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]serotonin,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
765,10085,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615867,2006-11-28 17:04:09,BautoJPO,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]serotonin,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
766,9841,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,B,,,,,,Frontal cortex,,Membrane,104744,H,4,Autocuration,7,ORIGINAL,1,,CHEMBL615868,2013-12-04 14:43:15,george_spelling,Ability to inhibit binding of titrated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,,,,,,,BAO_0000249,1870,,,CLD0,0,0,CLD0,
767,8822,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,B,,,Rattus norvegicus,10116,,Brain,,,104744,D,5,Autocuration,10,ORIGINAL,1,,CHEMBL615869,2006-04-20 15:42:47,admin_actype,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat.,,,,,,,BAO_0000249,955,,,CLD0,0,0,CLD0,
768,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,B,,,Rattus norvegicus,10116,,Frontal cortex,,,104744,D,5,Autocuration,2,ORIGINAL,1,,CHEMBL615870,2006-04-20 15:42:47,admin_actype,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3-H]-5-HT as a radioligand,,,,,,,BAO_0000221,1870,,,CLD0,0,0,CLD0,
769,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,B,,,Rattus norvegicus,10116,,Frontal cortex,,,104744,D,5,Autocuration,7,ORIGINAL,1,,CHEMBL615871,2006-04-20 15:42:47,admin_actype,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]-5-HT as a radioligand from rat frontal cortex homogenates,,,,,,,BAO_0000221,1870,,,CLD0,0,0,CLD0,
770,8868,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,B,,,,,,,,,104744,H,4,Autocuration,3,ORIGINAL,1,,CHEMBL615872,2006-11-28 16:58:32,BautoJPO,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand([3H]5-HT) binding assay,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
771,9036,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,2,ORIGINAL,1,,CHEMBL833492,2006-11-28 17:05:03,BautoJPO,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]serotonin.,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
772,11374,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,6,ORIGINAL,1,,CHEMBL615873,2006-04-20 15:42:47,admin_actype,Compound was evaluated for the inhibition of [3H]-5-HT (concentration of 12 nM) specific binding to rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
773,10881,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,B,,,,,,,,,104744,H,4,Autocuration,3,ORIGINAL,1,,CHEMBL615479,2006-04-20 15:42:47,admin_actype,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
774,8822,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,B,,,,,,,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615480,2006-04-20 15:42:47,admin_actype,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
775,9806,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,B,,,Rattus norvegicus,10116,,,,,104744,D,5,Autocuration,11,ORIGINAL,1,,CHEMBL615481,2006-11-23 12:25:28,BautoJPO,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand([3H]-5-HT) binding assay.,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
776,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,Cerebral cortex,,,104744,H,4,Autocuration,6,ORIGINAL,1,,CHEMBL872869,2011-01-19 17:04:46,LJB Desc Spelling,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
777,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,Cerebral cortex,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615482,2013-12-05 14:36:44,george_spelling,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor receptor in rat cerebral cortex,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
778,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615483,2011-01-19 17:04:26,LJB Desc Spelling,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]-5-HT in rat brain cortex at 10 uM,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
779,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,3,ORIGINAL,1,,CHEMBL615484,2006-11-28 16:58:32,BautoJPO,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]-5-HT in rat brain cortex at 10uM,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
780,8569,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,B,,,,,,,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615485,2006-11-28 17:04:09,BautoJPO,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H] serotonin as radioligand at 33microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
781,10062,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,B,,,Rattus norvegicus,10116,,,,,104744,D,5,Autocuration,10,ORIGINAL,1,,CHEMBL615486,2006-11-23 12:25:28,BautoJPO,Activity of the compound in radioreceptor binding assay by using [3H]5HT radioligand against 5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
782,4771,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,2,ORIGINAL,1,,CHEMBL615487,2010-10-26 17:10:29,SQL-abbr-desc,Ancillary Binding affinity of the compound towards rat 5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
783,10062,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,6,ORIGINAL,1,,CHEMBL615488,2006-11-23 12:25:28,BautoJPO,Binding affinity determined in radioreceptor binding assay by using [3H]5HT radioligand against 5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
784,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615489,2010-10-26 17:10:29,SQL-abbr-desc,"Binding affinity of the compound in radioreceptor binding assay by using
[3H]5HT radioligand against 5-hydroxytryptamine 1 receptor",,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
785,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,2,ORIGINAL,1,,CHEMBL615389,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound in radioreceptor binding assay by using [3H]5HT radioligand against 5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
786,15463,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,B,,,,,,Cerebral cortex,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615390,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
787,15463,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,B,,,,,,Cerebral cortex,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615391,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
788,9098,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,B,,,,,,,,,104744,H,4,Autocuration,3,ORIGINAL,1,,CHEMBL615392,2006-04-20 15:43:45,admin_actype,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
789,3070,Affinity for 5-hydroxytryptamine 1 receptor,B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,14,ORIGINAL,1,,CHEMBL615393,2006-04-20 15:43:45,admin_actype,Binding affinity towards 5-hydroxytryptamine 1 receptor was evaluated,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
790,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,B,,,,,,Brain,,,104744,H,4,Autocuration,2,ORIGINAL,1,,CHEMBL615394,2006-04-20 15:43:45,admin_actype,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]-5-HT in rat brain cortex,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
791,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615395,2006-11-28 16:58:32,BautoJPO,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]-5-HT in rat brain cortex at 10uM,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
792,6398,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,B,,,,,,,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615396,2006-04-20 15:43:45,admin_actype,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,,,,,,,BAO_0000224,,,,CLD0,0,0,CLD0,
793,1344,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,B,,,,,,Brain,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615397,2006-04-20 15:43:45,admin_actype,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]-HT radioligand assay,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
794,11963,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,Cerebral cortex,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615398,2006-11-28 16:58:32,BautoJPO,Displacement of binding of 3H-5HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
795,8908,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,14,ORIGINAL,1,,CHEMBL615399,2013-12-04 13:12:30,george_spelling,Evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using radioligand ([3H]spiperone) binding assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
796,9098,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,B,,,,,,,,,104744,H,4,Autocuration,42,ORIGINAL,1,,CHEMBL615400,2006-04-20 15:43:45,admin_actype,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
797,8841,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,B,,,Rattus norvegicus,10116,,Prefrontal cortex,,,104744,D,5,Autocuration,13,ORIGINAL,1,,CHEMBL615401,2006-04-20 15:43:45,admin_actype,Tested for binding affinity towards 5-hydroxytryptamine 1 receptor from prefrontal cortex of rats using [3H]-5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000221,451,,,CLD0,0,0,CLD0,
798,8814,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,B,,,Rattus norvegicus,10116,,,,,22226,U,0,Autocuration,14,ORIGINAL,1,,CHEMBL615402,2006-04-20 15:43:45,admin_actype,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand([3H]-5-HT) binding assay.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
799,11752,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,B,,,,,,,,,104744,H,4,Autocuration,6,ORIGINAL,1,,CHEMBL615403,2010-10-26 17:10:29,SQL-abbr-desc,The ability of the compound to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
800,11642,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,B,,,,,,Brain,,,104744,H,4,Autocuration,4,ORIGINAL,1,,CHEMBL615404,2010-10-26 17:10:29,SQL-abbr-desc,The binding affinity of the compound was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
801,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,B,,,,,,Cerebral cortex,,,104744,H,4,Autocuration,31,ORIGINAL,1,,CHEMBL615781,2006-11-28 17:04:09,BautoJPO,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
802,9231,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,B,,,,,,Brain,,,104744,H,4,Autocuration,60,ORIGINAL,1,,CHEMBL615782,2004-11-10 00:00:00,rmitter,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]-5-HT from rat brain synaptosomes,,,,,,,BAO_0000220,955,,,CLD0,0,0,CLD0,
803,11351,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,B,,,,,,Brain,,,104744,H,4,Autocuration,1,ORIGINAL,1,,CHEMBL615783,2011-01-19 17:05:09,LJB Desc Spelling,Inhibition constant of the compound (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H] serotonin as radioligand in rat brain cortex.,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
804,4639,Compound was tested for binding affinity against 5-HT1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,ORIGINAL,1,,CHEMBL873481,2006-04-20 15:44:07,admin_actype,Compound was tested for binding affinity against 5-HT1 receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
805,1205,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,22226,U,0,Autocuration,3,ORIGINAL,1,,CHEMBL615784,2006-04-20 15:42:47,admin_actype,Inhibitory concentration of the compound was determined against 5-hydroxytryptamine 1 receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
806,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,B,,,,,,,,,10576,H,8,Expert,5,ORIGINAL,1,,CHEMBL615785,2006-11-28 16:58:32,BautoJPO,Concentration of the compound necessary to acheive half maximal inhibition of [3H]-8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1uM,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
807,13241,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",F,,,,,,,,,10576,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615786,2006-04-20 15:42:24,admin_actype,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
808,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615787,2006-04-20 15:42:24,admin_actype,Agonistic activity (induction of fore-paw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
809,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615788,2006-04-20 15:42:24,admin_actype,Agonistic activity (induction of fore-paw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
810,12438,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,F,,,,,,,,,10576,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL767044,2006-04-20 15:42:24,admin_actype,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
811,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615789,2006-04-20 15:42:35,admin_actype,Agonistic activity (induction of fore-paw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
812,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615790,2006-04-20 15:42:35,admin_actype,Agonistic activity (induction of fore-paw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
813,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,F,,,,,,,,,10576,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615813,2011-06-09 17:19:30,F_type_fix,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY293284 trained rats,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
814,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,F,,,,,,,GH4ZD10,,10576,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615814,2011-01-19 17:05:06,LJB Desc Spelling,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
815,15535,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,F,,,,,,,GH4ZD10,,51,H,8,Expert,17,ORIGINAL,1,,CHEMBL615815,2006-11-23 12:25:29,BautoJPO,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
816,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,F,,,,,,,GH4ZD10,,10576,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615816,2011-01-19 17:04:22,LJB Desc Spelling,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
817,9888,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,B,,,,,,Brain,,,10576,H,8,Expert,15,ORIGINAL,1,,CHEMBL615817,2005-03-17 00:00:00,rmyers,Compound was evaluated for binding affinity at [3H]-8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,,,,,,,BAO_0000249,955,,,CLD0,0,0,CLD0,
818,10085,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615818,2006-11-28 16:58:32,BautoJPO,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
819,10085,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615819,2006-11-28 16:58:32,BautoJPO,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
820,17331,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,B,,,,,,Hippocampus,,Membrane,10576,H,8,Expert,102,ORIGINAL,1,,CHEMBL615820,2006-11-23 12:25:29,BautoJPO,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]-8-OH-DPAT from rat hippocampus mambranes,,,,,,,BAO_0000249,10000000,,,CLD0,0,0,CLD0,
821,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116,,Hippocampus,,,10576,D,9,Expert,1,ORIGINAL,1,,CHEMBL615821,2006-11-28 16:58:32,BautoJPO,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
822,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,B,,,Rattus norvegicus,10116,,Hippocampus,,,10576,D,9,Expert,1,ORIGINAL,1,,CHEMBL615822,2006-11-23 12:25:29,BautoJPO,"Binding affinity against 5-hydroxytryptamine 1A receptor, in rat hippocampal tissue using [3H]5-HT as radioligand",,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
823,10845,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,7,ORIGINAL,1,,CHEMBL615823,2006-11-28 16:58:32,BautoJPO,"Binding affinity against 5-hydroxytryptamine 1A receptorusing in rat hippocampal tissue
using [3H]8-OH-DPAT as radioligand",,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
824,10845,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,B,,,Rattus norvegicus,10116,,Hippocampus,,,10576,D,9,Expert,13,ORIGINAL,1,,CHEMBL615824,2013-12-05 18:44:55,george_spelling,"Binding affinity against 5-hydroxytryptamine 1A receptorusing in rat hippocampal tissue
using [3H]8-OH-DPAT as radioligand;IA-Inactive",,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
825,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,B,,,Rattus norvegicus,10116,,Hippocampus,,,10576,D,9,Expert,1,ORIGINAL,1,,CHEMBL615825,2006-11-28 16:58:32,BautoJPO,"Binding affinity against5-hydroxytryptamine 1A receptor, in rat hippocampal tissue using [3H]5-HTas radioligand",,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
826,13730,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,19,ORIGINAL,1,,CHEMBL615826,2006-04-20 15:42:47,admin_actype,Binding affinity of compound towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
827,13508,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,16,ORIGINAL,1,,CHEMBL615827,2006-04-20 15:42:47,admin_actype,Binding affinity of the compound against 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000249,10000000,,,CLD0,0,0,CLD0,
828,13508,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,10,ORIGINAL,1,,CHEMBL615828,2006-04-20 15:42:47,admin_actype,Binding affinity of the compound against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000249,10000000,,,CLD0,0,0,CLD0,
829,12073,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,25,ORIGINAL,1,,CHEMBL615829,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
830,4671,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615830,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
831,13631,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,58,ORIGINAL,1,,CHEMBL615831,2006-11-28 16:58:32,BautoJPO,Binding affinity of the compound towards serotonin 5HT1A receptor was determined in rat hippocampus using [3H]-8-OH-DPAT as ligand,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
832,12438,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615832,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound was measured against serotonin 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
833,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615833,2006-11-28 17:04:09,BautoJPO,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH DPAT as radioligand,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
834,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615834,2006-11-28 17:05:09,BautoJPO,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH DPAT as radioligand,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
835,12352,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,B,,,,,,Hippocampus,,,10576,H,8,Intermediate,44,ORIGINAL,1,,CHEMBL615835,2006-11-28 16:58:32,BautoJPO,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,,,,,,,BAO_0000249,10000000,,,CLD0,0,0,CLD0,
836,14732,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615836,2006-04-20 15:42:47,admin_actype,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in rat hippocampal membrane.,,,,,,,BAO_0000249,10000000,,,CLD0,0,0,CLD0,
837,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,B,,,Rattus norvegicus,10116,,Brain,,,10576,D,9,Expert,8,ORIGINAL,1,,CHEMBL615837,2006-04-20 15:42:47,admin_actype,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]-8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
838,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,B,,,Rattus norvegicus,10116,,Brain,,,10576,D,9,Expert,6,ORIGINAL,1,,CHEMBL615838,2006-04-20 15:42:47,admin_actype,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]-8-hydroxy-2-(di-n-propylamine)tetralin as radioligand;ND-Not determined,,,,,,,BAO_0000221,955,,,CLD0,0,0,CLD0,
839,13657,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",B,,,,,,Hippocampus,,,10576,H,8,Expert,22,ORIGINAL,1,,CHEMBL615839,2006-04-20 15:42:47,admin_actype,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",,,,,,,BAO_0000249,10000000,,,CLD0,0,0,CLD0,
840,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL884525,2006-11-23 12:25:26,BautoJPO,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-0H-DPAT as radioligand,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
841,2014,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,B,,,,,,Cerebral cortex,,,10576,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615840,2006-04-20 15:42:47,admin_actype,Compound was evaluated for its ability to displace [3H]-8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,,,,,,BAO_0000249,956,,,CLD0,0,0,CLD0,
842,3086,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,24,ORIGINAL,1,,CHEMBL615405,2006-11-23 12:25:28,BautoJPO,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
843,15854,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,B,,,,,,Frontal cortex,,,10576,H,8,Expert,19,ORIGINAL,1,,CHEMBL615406,2006-11-23 12:25:28,BautoJPO,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,,,,,,BAO_0000221,1870,,,CLD0,0,0,CLD0,
844,10922,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,B,,,,,,Hippocampus,,,10576,H,8,Expert,28,ORIGINAL,1,,CHEMBL615900,2006-04-20 15:42:47,admin_actype,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT radioligand in hippocampus tissue,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
845,13346,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,B,,,,,,Hippocampus,,,10576,H,8,Expert,21,ORIGINAL,1,,CHEMBL615901,2006-04-20 15:42:47,admin_actype,Compound was tested in vitro for its ability to displace [3H]-8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
846,15311,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,B,,,,,,,,,10576,H,8,Expert,20,ORIGINAL,1,,CHEMBL615902,2006-04-20 15:42:47,admin_actype,Compound was tested in vitro for its inhibitory activity against 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT radioligand binding assay,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
847,10922,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615903,2006-04-20 15:42:47,admin_actype,Compoundwas measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT radioligand in hippocampus tissue,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
848,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,B,,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615904,2010-10-26 17:10:29,SQL-abbr-desc,"Concentration of the compound necessary to acheive half maximal inhibition of [3H]-8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor
at 1uM",,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
849,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,B,,,,,,,,,10576,H,8,Expert,14,ORIGINAL,1,,CHEMBL615905,2006-11-23 12:25:29,BautoJPO,Concentration of the compound necessary to acheive half maximal inhibition of [3H]-8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1uM,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
850,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,B,,,,,,,,,10576,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615906,2006-04-20 15:42:47,admin_actype,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
851,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,F,,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615907,2006-04-20 15:42:47,admin_actype,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
852,12304,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,B,,,,,,Cerebral cortex,,,10576,H,8,Expert,15,ORIGINAL,1,,CHEMBL615908,2010-10-26 17:10:29,SQL-abbr-desc,In vitro ability of the compound to inhibit binding of radioligand [3H]-8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
853,15789,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615909,2006-04-20 15:42:47,admin_actype,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
854,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615910,2006-04-20 15:42:47,admin_actype,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
855,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",B,,,,,,,,,10576,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615911,2006-04-20 15:42:47,admin_actype,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand.",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
856,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615912,2013-12-05 14:36:44,george_spelling,"In vitro binding activity against 5-hydroxytryptamine 1A receptor receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
857,16693,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,B,,,,,,Cerebral cortex,,,10576,H,8,Expert,20,ORIGINAL,1,,CHEMBL615913,2006-11-23 12:25:29,BautoJPO,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8OH-DPAT as radioligand,,,,,,,BAO_0000221,956,,,CLD0,0,0,CLD0,
858,13276,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,31,ORIGINAL,1,,CHEMBL615914,2006-04-20 15:42:47,admin_actype,In vitro binding affinity of the compound was measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
859,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615915,2006-04-20 15:42:47,admin_actype,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I]-(R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
860,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,B,,,,,,,,,10576,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615916,2006-04-20 15:42:47,admin_actype,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
861,12443,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,B,,,,,,,,,10576,H,8,Expert,18,ORIGINAL,1,,CHEMBL615917,2006-11-28 17:04:09,BautoJPO,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H] tetralin,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
862,13830,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,45,ORIGINAL,1,,CHEMBL615918,2006-04-20 15:42:47,admin_actype,In vitro inhibitory activity of the compound against [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
863,14286,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,B,,,,,,Hippocampus,,,10576,H,8,Expert,28,ORIGINAL,1,,CHEMBL615919,2006-04-20 15:42:47,admin_actype,In vitro inhibitory concentration of the compound against radioligand [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,,,,,,,BAO_0000249,10000000,,,CLD0,0,0,CLD0,
864,14356,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,B,,,Rattus norvegicus,10116,,Hippocampus,,,10576,D,9,Expert,1,ORIGINAL,1,,CHEMBL615920,2006-04-20 15:42:47,admin_actype,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
865,15306,Inhibition concentration against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615921,2010-10-26 17:10:29,SQL-abbr-desc,Inhibition concentration of the compound against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
866,15306,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),B,,,,,,,,,10576,H,8,Expert,26,ORIGINAL,1,,CHEMBL615922,2006-04-20 15:42:47,admin_actype,Inhibition concentration of the compound against 5-hydroxytryptamine 1A receptor; (Inactive at >1000 nM concentration),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
867,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",F,,,Rattus norvegicus,10116,,,,,10576,D,9,Expert,8,ORIGINAL,1,,CHEMBL881290,2006-12-04 17:22:55,BautoJPO,Inhibition of (+)-8-OH-DPAT stimulated [35S]GTPgammaS binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes,,,,,,,BAO_0000249,,,,CLD0,0,0,CLD0,
868,3651,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",B,,,,,,Hippocampus,,,10576,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615923,2006-04-20 15:42:47,admin_actype,"Inhibition of [3H]-8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
869,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,F,,,,,,Hippocampus,,,10576,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615924,2006-04-20 15:42:47,admin_actype,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
870,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,F,,,,,,Hippocampus,,,10576,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615925,2006-04-20 15:42:47,admin_actype,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
871,14178,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116,,,,,10576,D,9,Expert,6,ORIGINAL,1,,CHEMBL615926,2006-12-13 00:00:00,ylight,Inhibition of radiolabelled [3H]8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
872,10639,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116,,,,,10576,D,9,Expert,13,ORIGINAL,1,,CHEMBL615927,2006-04-20 15:42:47,admin_actype,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]-8-OH-DPAT as the radioligand.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
873,12306,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615928,2006-04-20 15:42:47,admin_actype,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
874,1348,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,B,,,Rattus norvegicus,10116,,,,,10576,D,9,Expert,10,ORIGINAL,1,,CHEMBL615929,2013-12-05 14:36:45,george_spelling,Inhibitory activity against 5-hydroxytryptamine 1A receptor receptor subtype,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
875,13605,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615930,2006-11-28 16:58:32,BautoJPO,Inhibitory activity against [3H]DPAT binding to 5HT1A receptor in rat hippocampus,,,,,,,BAO_0000221,10000000,,,CLD0,0,0,CLD0,
876,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615931,2006-04-20 15:42:47,admin_actype,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
877,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615932,2006-04-20 15:42:47,admin_actype,Inhibition concentration against binding of radioligand [35]GTPgammaS in CHO cells expressing 5-hydroxytryptamine 1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
878,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615933,2006-04-20 15:42:47,admin_actype,Inhibition concentrationagainst binding of radioligand [35]GTPgammaS in CHO cells expressing 5-hydroxytryptamine 1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
879,15267,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615934,2006-11-28 17:04:09,BautoJPO,Inhibition of [3H] 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
880,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615935,2010-10-26 17:10:29,SQL-abbr-desc,The binding affinity of the compound at the 5-hydroxytryptamine 1A receptor determined using [3H]-5-CT; Not tested,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
881,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615936,2006-12-04 17:22:55,BautoJPO,Agonsitic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTPgammaS stimulated cAMP assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
882,4751,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,B,,,,,,,CHO,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615937,2011-01-19 17:05:11,LJB Desc Spelling,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 microM,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
883,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615938,2011-01-19 17:04:31,LJB Desc Spelling,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
884,3805,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615797,2010-09-23 11:52:22,SQL-abbr-desc,Compound was evaluated in vitro for the binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
885,5640,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615798,2010-10-26 17:10:29,SQL-abbr-desc,In vitro binding affinity of the compound towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
886,6563,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL872870,2006-11-23 12:25:27,BautoJPO,Inhibition of [3H]-8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000nM compound concentration,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
887,5548,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615799,2006-11-28 16:58:32,BautoJPO,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100nM concentration,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
888,6347,Percent binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615800,2010-10-26 17:10:29,SQL-abbr-desc,Percent binding affinity of the compound against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
889,17296,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615801,2006-11-28 16:58:32,BautoJPO,Intrinsic activity of the compound was determined for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gammaS,,,,,,722,BAO_0000219,,,,CLD0,0,0,CLD0,
890,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,B,,,,,,Jugular vein,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615802,2006-04-20 15:43:44,admin_actype,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,,,,,,,BAO_0000221,4711,,,CLD0,0,0,CLD0,
891,15740,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615803,2006-04-20 15:43:44,admin_actype,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
892,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",F,,,,,,,,,51,H,8,Expert,19,ORIGINAL,1,,CHEMBL835002,2006-12-04 17:22:57,BautoJPO,5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTPgS binding that was induced by 5-HT,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
893,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",F,,,,,,,,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615804,2013-12-19 14:16:36,george_spelling,5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTPgS binding that was induced by 5-HT; Ki (nM) : not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
894,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,B,,,,,,,HeLa,,51,H,8,Expert,29,ORIGINAL,1,,CHEMBL615805,2006-11-28 16:58:32,BautoJPO,Ability to displace [3H]5-CT (2.0nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
895,4751,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,B,,,,,,,CHO,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615806,2006-11-28 16:58:32,BautoJPO,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
896,6491,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL615807,2006-04-20 15:43:45,admin_actype,Affinity of the compound towards human 5-hydroxytryptamine 1A receptor serotonin receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
897,4707,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,B,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615808,2006-11-23 12:25:29,BautoJPO,Binding affinitty towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
898,13910,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL615809,2006-04-20 15:43:45,admin_actype,Binding affinity against 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
899,16190,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,B,,,,,,,HeLa,,51,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615810,2006-04-20 15:43:45,admin_actype,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]-5-HT,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
900,16633,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615811,2006-04-20 15:43:45,admin_actype,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
901,11898,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615812,2006-11-28 17:04:09,BautoJPO,Binding affinity against [3H] -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
902,11898,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL615751,2006-04-20 15:43:45,admin_actype,Binding affinity against [3H]-8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
903,14331,Binding affinity against human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615752,2006-04-20 15:43:45,admin_actype,Binding affinity against human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
904,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,B,,,,,,,CHO,,51,H,8,Expert,30,ORIGINAL,1,,CHEMBL615753,2006-04-20 15:43:45,admin_actype,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]-8-OH-DPAT radioligand,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
905,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,B,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615754,2006-04-20 15:43:45,admin_actype,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]-8-OH-DPAT radioligand; nd=not determined,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
906,3307,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615755,2006-04-20 15:43:45,admin_actype,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
907,6563,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,B,,,Homo sapiens,9606,,,CHO,,51,D,9,Expert,14,ORIGINAL,1,,CHEMBL615756,2006-04-20 15:43:45,admin_actype,Binding affinity of compound towards human 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
908,14165,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL615757,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
909,5732,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615758,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound towards cloned human 5-hydroxytryptamine 1A receptor was determined,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
910,13366,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,B,,,,,,,,,51,H,8,Expert,21,ORIGINAL,1,,CHEMBL615759,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound towards cloned human 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
911,17626,Binding affinity towards human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615760,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound towards human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
912,6588,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,B,,,,,,,HeLa,,51,H,8,Expert,10,ORIGINAL,1,,CHEMBL615761,2006-11-23 12:25:29,BautoJPO,Binding affinity of the compound towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]-5HT radioligand from the cloned receptor expressed in HeLa cells,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
913,16209,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL872104,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound towards human 5-hydroxytryptamine 1A receptor was determined using [3H]serotonin as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
914,15463,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615762,2013-12-05 18:44:55,george_spelling,Binding affinity of the compound towards recombinant human 5-hydroxytryptamine 1A receptor  was determined using [3H]8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
915,15463,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615763,2013-12-05 14:36:46,george_spelling,Binding affinity of the compound towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor receptor was determined using [3H]8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
916,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615764,2006-11-28 17:04:09,BautoJPO,Binding affinity of the compound was determined for recombinant human 5-hydroxytryptamine 1A receptor using [3H]serotonin as radioligand.,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
917,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),B,,,,,,,Cell line,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL615765,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was determined on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),,,,,,1167,BAO_0000219,,,,CLD0,0,0,CLD0,
918,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),B,,,,,,,,,51,H,8,Autocuration,7,ORIGINAL,1,,CHEMBL615766,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was determined on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
919,5548,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615767,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was determined towards 5-HT1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
920,5548,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,22,ORIGINAL,1,,CHEMBL615768,2013-12-05 14:37:10,george_spelling,Binding affinity of the compound was determined towards 5-hydroxytryptamine 1A receptor receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
921,5548,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615769,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was determined towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
922,6876,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,B,,,,,,,,,51,H,8,Expert,15,ORIGINAL,1,,CHEMBL615770,2006-04-20 15:43:45,admin_actype,Binding affinity of the compound was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
923,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615771,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
924,17785,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,B,,,,,,,,,51,H,8,Expert,81,ORIGINAL,1,,CHEMBL615772,2006-11-28 16:58:32,BautoJPO,Binding affinity of the compound was measured towards human 5-hydroxytryptamine 1A receptor using [3H]8-hydroxy-2-(di-n-propylamine) tetraline (3H-8-OH-DPAT) as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
925,6013,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,4,ORIGINAL,1,,CHEMBL615773,2006-04-20 15:43:45,admin_actype,Binding affinity towards 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
926,5929,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,28,ORIGINAL,1,,CHEMBL615774,2006-04-20 15:43:45,admin_actype,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
927,16633,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615775,2006-04-20 15:43:45,admin_actype,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
928,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL615776,2006-04-20 15:43:45,admin_actype,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
929,16026,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,20,ORIGINAL,1,,CHEMBL615777,2006-04-20 15:43:45,admin_actype,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
930,12469,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,B,,,,,,,AK,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL615778,2006-04-20 15:43:45,admin_actype,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
931,15874,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,9,ORIGINAL,1,,CHEMBL615779,2006-11-23 12:25:29,BautoJPO,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by[3H]8-OH-DPAT,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
932,15874,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,,,,,,,51,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL615780,2006-11-28 16:58:32,BautoJPO,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
933,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616298,2006-04-20 15:43:45,admin_actype,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
934,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL616299,2013-12-05 14:35:05,george_spelling,Compound was evaluated for its binding affinity towards human human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
935,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL616300,2006-04-20 15:43:45,admin_actype,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,,,,,,485,BAO_0000219,,,,CLD0,0,0,CLD0,
936,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,F,,,,,,,CHO-K1,,51,H,8,Expert,19,ORIGINAL,1,,CHEMBL616301,2006-04-20 15:43:45,admin_actype,Compound was tested for it's ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,,,,,,485,BAO_0000219,,,,CLD0,0,0,CLD0,
937,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616302,2006-11-28 17:05:09,BautoJPO,Compound was tested in vitro for the inhibition of [3H] 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
938,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616117,2006-11-28 17:04:09,BautoJPO,Compound was tested in vitro for the inhibition of [3H] 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
939,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616118,2006-11-28 17:05:09,BautoJPO,Compound was tested in vitro for the inhibition of [3H] 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
940,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616119,2006-11-28 17:04:09,BautoJPO,Compound was tested in vitro for the inhibition of [3H] 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
941,3445,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,B,,,Homo sapiens,9606,,,HeLa,,51,D,9,Expert,11,ORIGINAL,1,,CHEMBL616120,2006-11-28 17:05:09,BautoJPO,Displacement of specific [3H] 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
942,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL616121,2006-11-28 16:58:32,BautoJPO,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
943,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616122,2006-11-28 16:58:32,BautoJPO,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
944,17626,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616123,2010-10-26 17:10:29,SQL-abbr-desc,In vitro binding affinity of the compound tested on human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
945,4234,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,11,ORIGINAL,1,,CHEMBL616124,2006-04-20 15:43:45,admin_actype,In vitro binding affinity of the compound to human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
946,5640,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,B,,,,,,,,,51,H,8,Expert,21,ORIGINAL,1,,CHEMBL616125,2006-04-20 15:43:45,admin_actype,In vitro binding affinity of the compound towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
947,5272,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116,,,,,51,H,8,Expert,10,ORIGINAL,1,,CHEMBL616126,2006-06-26 00:00:00,davidm,In vitro binding affinity of the compound towards Human 5-hydroxytryptamine 1A receptor was determined by the displacement of [3H]-8-OH-DPAT,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
948,4622,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,B,,,,,,,CHO,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL616127,2010-10-26 17:10:29,SQL-abbr-desc,In vitro binding affinity of the compound towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
949,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,33,ORIGINAL,1,,CHEMBL616128,2006-04-20 15:43:45,admin_actype,In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
950,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,B,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL616129,2006-11-28 17:04:09,BautoJPO,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]-8-hydroxy-DPAT radio ligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
951,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,5,ORIGINAL,1,,CHEMBL616130,2006-04-20 15:43:45,admin_actype,In vitro receptor binding affinity of the compound for cloned human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
952,15267,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616131,2006-11-28 17:04:09,BautoJPO,Inhibition of [3H] OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
953,17158,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,B,,,,,,,HeLa,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL616132,2006-04-20 15:43:45,admin_actype,Inhibition of [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotoninergic receptor in human HeLa cells,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
954,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,B,,,Homo sapiens,9606,,,HeLa,,51,D,9,Expert,10,ORIGINAL,1,,CHEMBL616133,2006-04-20 15:43:45,admin_actype,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
955,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,8,ORIGINAL,1,,CHEMBL616134,2006-04-20 15:43:45,admin_actype,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
956,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,B,,,,,,,,,51,H,8,Autocuration,5,ORIGINAL,1,,CHEMBL616135,2010-10-26 17:10:29,SQL-abbr-desc,The binding affinity of the compound at the 5-hydroxytryptamine 1A receptor determined using [3H]-5-CT,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
957,2391,Affinity for 5-hydroxytryptamine 1A receptor subtype,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,14,ORIGINAL,1,,CHEMBL616136,2006-04-20 15:43:45,admin_actype,The compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor subtype,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
958,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616137,2006-04-20 15:43:45,admin_actype,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
959,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,B,,,,,,,,,51,H,8,Autocuration,6,ORIGINAL,1,,CHEMBL872105,2006-04-20 15:43:45,admin_actype,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
960,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616138,2006-04-20 15:43:45,admin_actype,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
961,13051,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606,,,,,51,D,9,Expert,23,ORIGINAL,1,,CHEMBL616139,2006-04-20 15:43:45,admin_actype,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
962,16026,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",F,,,,,,,HeLa,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616140,2006-12-04 17:22:55,BautoJPO,Ability to influence the binding of [35S]GTP-gamma-S to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
963,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,B,,,,,,,,,51,H,8,Expert,5,ORIGINAL,1,,CHEMBL616141,2005-03-17 00:00:00,rmyers,In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
964,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616142,2004-10-31 12:48:03,admin,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
965,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616143,2004-10-31 12:48:03,admin,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand; ND means Not determined,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
966,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616144,2013-12-19 14:17:24,george_spelling,Ability to displace [3H]5-CT (2.0nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor ; NT denotes not tested,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
967,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616145,2013-12-19 14:17:24,george_spelling,Ability to displace [3H]5-CT (2.0nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor ; NT=not tested,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
968,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616012,2006-11-28 16:58:32,BautoJPO,Ability to displace [3H]5-CT (2.0nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
969,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616013,2013-12-19 14:17:24,george_spelling,Ability to displace [3H]5-CT (2.0nM) from HeLa cells of human5-hydroxytryptamine 1A receptor ; NT denotes not tested,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
970,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616014,2013-12-19 14:17:24,george_spelling,Agonist efficacy of [35S]GTPgammaS binding to 5-hydroxytryptamine 1A receptor compared with 5-HT. ; NT is not tested,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
971,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616015,2013-12-19 14:25:52,george_spelling,Agonist efficacy of [35S]GTPgammaS binding to 5-hydroxytryptamine 1A receptor compared with 5-HT. ;NT is not tested,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
972,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616016,2011-07-18 11:35:36,F_type_fix,Agonist efficacy of [35S]GTPgammaS binding to 5-hydroxytryptamine 1A receptorcompared with 5-HT.; NT is not tested,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
973,16394,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,F,In vivo,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616017,2013-12-19 14:17:24,george_spelling,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration ; NT is not tested,,,,,,,BAO_0000218,,,,CLD0,0,0,CLD0,
974,16394,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,B,,,,,,,ovary,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616018,2004-10-31 12:48:03,admin,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,,,,,,,BAO_0000219,,,,CLD0,0,0,CLD0,
975,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616019,2011-01-19 17:04:42,LJB Desc Spelling,EC50 for inhibition of 50 microM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
976,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL616020,2011-01-19 17:04:42,LJB Desc Spelling,EC50 for inhibition of 50 microM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
977,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL858018,2006-11-23 12:25:29,BautoJPO,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000357,,,,CLD0,0,0,CLD0,
978,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,3,ORIGINAL,1,,CHEMBL616021,2010-10-26 17:10:29,SQL-abbr-desc,Binding affinity of the compound against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gammaS,,,,,,722,BAO_0000219,,,,CLD0,0,0,CLD0,
979,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",F,,,,,,,,,51,H,8,Expert,19,ORIGINAL,1,,CHEMBL616022,2006-12-04 17:22:51,BautoJPO,Stimulation of binding of[35S]GTPgammaS to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1microM,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
980,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616023,2006-12-04 17:22:55,BautoJPO,Stimulation of binding of[35S]GTPgammaS to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1microM; ND means Not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
981,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",F,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616024,2006-12-04 17:22:51,BautoJPO,Stimulation of binding of[35S]GTPgammaS to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1microM; ND means not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
982,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",F,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616025,2006-12-04 17:22:55,BautoJPO,Stimulation of binding of[35S]GTPgammaS to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1microM; Not determined,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
983,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616026,2004-10-31 12:48:03,admin,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
984,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",F,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616027,2011-07-18 11:35:36,F_type_fix,Agonist efficacy of [35S]GTPgammaS binding to 5-hydroxytryptamine 1A receptor compared with 5-HT,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
985,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",F,,,Homo sapiens,9606,,,,,51,D,9,Expert,13,ORIGINAL,1,,CHEMBL616028,2011-07-18 11:35:36,F_type_fix,Agonist efficacy of [35S]GTPgammaS binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
986,3445,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,7,ORIGINAL,1,,CHEMBL616029,2006-05-02 00:00:00,ylight,Percent effficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
987,4316,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,B,,,,,,,CHO,,51,H,8,Expert,25,ORIGINAL,1,,CHEMBL616030,2006-04-20 15:43:24,admin_actype,Binding affinity of the compound (1uM) for 5-hydroxytryptamine 1A receptor was determined by incubating CHO cells transfected with human 5-hydroxytryptamine 1A receptor with [3H]-8-OH-DPAT,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
988,4316,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,B,,,,,,,CHO,,51,H,8,Expert,1,ORIGINAL,1,,CHEMBL616031,2006-04-20 15:43:24,admin_actype,Binding affinity of the compound (1uM) was determined by incubating CHO cells transfected with human 5-hydroxytryptamine 1A receptor with [3H]-8-OH-DPAT,,,,,,449,BAO_0000219,,,,CLD0,0,0,CLD0,
989,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,1,ORIGINAL,1,,CHEMBL616032,2006-03-30 00:00:00,davidm,Agonist efficacy of the compound on 5-hydroxytryptamine 1A receptor subtype,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
990,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,F,,,Homo sapiens,9606,,,,,51,D,9,Expert,7,ORIGINAL,1,,CHEMBL616033,2006-03-30 00:00:00,davidm,Agonist efficacy of the compound on 5-hydroxytryptamine 1A receptor subtype.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
991,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616034,2013-12-05 18:44:55,george_spelling,Maximum binding affinity of the compound was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A  serotoninergic receptors.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
992,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,2,ORIGINAL,1,,CHEMBL616035,2010-10-26 17:10:29,SQL-abbr-desc,Maximum binding affinity of the compound was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotoninergic receptors.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
993,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616036,2010-10-26 17:10:29,SQL-abbr-desc,Maximum binding affinity of the compound was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
994,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616037,2013-12-05 18:44:55,george_spelling,Agonist efficacy of the compound was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A  serotoninergic receptors.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
995,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616038,2011-07-18 11:35:36,F_type_fix,Agonist efficacy of the compound was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotoninergic receptors.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
996,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616039,2011-07-18 11:35:36,F_type_fix,Agonist efficacy of the compound was evaluated as ([35S]GTP binding on5-hydroxytryptamine 1A serotoninergic receptors.,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
997,15042,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,ORIGINAL,1,,CHEMBL616040,2011-07-18 11:35:36,F_type_fix,Agonist efficacy of the compound was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,,,,,,BAO_0000019,,,,CLD0,0,0,CLD0,
998,15180,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606,,,HeLa,,51,D,9,Expert,4,ORIGINAL,1,,CHEMBL616041,2006-03-30 00:00:00,davidm,Concentration of the compound required to obtain 50% maximal stimulation of [35S]-GTP gamaS binding to 5-HT1A receptors of cell membranes from HeLa cells transfected with human cloned 5-hydroxytryptamine 1A receptor,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
999,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606,,,HeLa,,51,D,9,Expert,2,ORIGINAL,1,,CHEMBL616042,2013-12-04 13:57:03,george_spelling,Negative logorithm of concentration required to obtain 50% maximal stimulation of [35S]-GTP gamaS binding to 5-HT1A receptors of cell membranes from HeLa cells transfected with human cloned 5-HT1A receptors,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
1000,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606,,,HeLa,,51,D,9,Expert,2,ORIGINAL,1,,CHEMBL616043,2013-12-04 13:57:04,george_spelling,Negative logorithm of concentration required to obtain 50% maximal stimulation of [35S]-GTP gamaS binding to 5-HT1A receptors of cell membranes from HeLa cells transfected with human cloned 5-hydroxytryptamine 1A receptor,,,,,,308,BAO_0000219,,,,CLD0,0,0,CLD0,
